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1I N T R O D U C T I O N
T he diagnosis of neuro-degenerative diseases characterisedby slow progression is difficult, especially at an earlystage. These diseases have continued to affect the el-
derly [Berg, 2008], especially in developed countries where life
expectancy is high. Some of these disorders include Parkin-
son’s disease (PD), progressive supranuclear palsy (PSP), multi-
system atrophy (MSA), Alzheimer’s disease (AD), frontotem-
poral dementia (FTD), and dementia with Lewy bodies (DLB),
to mention a few. Parkinson’s disease (PD) is a progressive dis-
order which causes slow motion and rigidity in the body. PD is
characterized by neuronal loss in the substantia nigra and other
brain regions, also associated with the formation of intracel-
lular protein inclusions known as Lewy bodies [Shulman and
De Jager, 2009]. On the other hand, Alzheimer’s disease (AD)
is associated with progressive memory loss, as well as judg-
ment and decision making impairments, according to statistics
collected by Guttmacher et al. [2003].
There is increasing interest to use neuroimaging techniques
in the hope to discover biomarkers, that is, abnormal patterns
of morphology, energy consumption or network activity of
the brain which are characteristic for such diseases. Many in
vivo brain imaging techniques are nowadays available for this
purpose; see Table 1.1. Positron Emission Tomography (PET)
has been applied in many medical studies due to its capa-
bility to show metabolism of the brain. PET scans reveal the
amount of metabolic activity in various parts of the brain. PET
is used for clinical diagnosis of brain diseases. For example,
in patients with idiopathic Parkinson’s disease (IPD), a pat-
tern of increased metabolism in specific brain areas was found
on the basis of Positron Emission Tomography (PET) imaging
[Fodero-Tavoletti et al., 2009]. This method is based on visual
comparison of patient data with disease-specific templates that
contain regions of interest (ROIs), and is therefore quite sub-
jective. Other studies to detect and differentiate parkinsonian
syndromes include Eckert et al. [2005, 2008]; Hellwig et al.
[2012]; Wu et al. [2013]; Garraux et al. [2013]. On the other
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hand, PET has been used in previous studies to test for depres-
sion and dementia in patients with neurodegenerative diseases.
For example, as reported by Chow et al. [2009], PET was used
to measure the availability of cortical serotonin receptors in
older subjects. PET can also be used to perform efficient di-
agnosis [Yun et al., 2001]. Newly developed PET techniques
use multivariate statistical analysis to identify disease-related
network patterns of brain metabolism [Frackowiak et al., 2003].
Although this thesis focuses on PET for image acquisition,
we briefly mention some other methods, also because some
of these may be combined with PET in future work. A large
collection of brain imaging techniques is based upon Magnetic
Resonance Imaging (MRI) [Golder, 2002]. In contrast to PET,
which requires administering radioactive tracers to the subject
being scanned, MRI is a fully non-invasive method with no
known health implications. In fact, distinct spatial patterns of
cortical atrophy have been found from structural MRI images
by a technique called voxel-based morphometry (VBM) [Chéte-
lat et al., 2008; Berg, 2008]. This method considers all voxels in a
brain volume, and gives quantitative estimates of the grey and
white matter volumes without assuming any a priori regions of
interest. Another MRI-based technique, called Diffusion Tensor
Imaging (DTI), is able to measure the amount of anisotropy
of water diffusion, from which the orientation of nerve fiber
bundles in brain white matter can be inferred [Basser et al.,
1994]. Also, in the study by Ito et al. [2006] measures like ap-
parent diffusion coefficient (ADC) and fractional anisotropy
(FA) have been used to evaluate the degree of tissue degenera-
tion in diseases like Parkinson’s and multiple system atrophy.
In addition, DTI-tractography can be used to visualise nerve
fiber tracts and study abnormal connectivity patterns between
brain regions. Furthermore, MRI-based techniques such as Arte-
rial Spin Labelling (ASL) and Susceptibility-Weighted Imaging
(SWI) allow for quantitative assessment of tissue perfusion and
levels of venous blood, hemorrhage, and iron storage in the
brain, respectively. Additionally, the MRI-technique known as
functional magnetic resonance imaging (fMRI) determines and
visualises changes in brain activity that are elicited by asking
test persons to carry out specific cognitive or sensorimotor tasks.
A recent addition is “resting-state” fMRI, where the subject in
the MRI-scanner is imaged without external stimulus; the data
are processed to derive brain connectivity patterns which are
assumed to represent a default-mode network [Salvador et al.,
2
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2005] and other networks mentioned by Van Den Heuvel and
Pol [2010]. This network includes regions that are known to be
impaired in certain types of neuro-degenerative diseases [Gre-
icius, 2008]. For completeness, we also have listed some imaging
techniques in Table 1.1 which can detect neuronal activity, like
electroencephalography (EEG) and magnetoencephalography
(MEG).
Table 1.1: In vivo brain imaging techniques. See Figure 1.1 for a PET
brain image example.
Technique Represents Physical effect
CT anatomy X-ray attenuation
PET metabolism radioactive decay
MRI anatomy magnetic resonance
fMRI metabolism blood deoxygenation
DTI nerve fibers anisotropic diffusion
MEG neuronal activity magnetic signals
EEG neuronal activity electric signals
Figure 1.1: In vivo brain imaging techniques: example of a PET brain
image.
Although some success has been obtained by the techniques
mentioned above, a major problem is that each of the separate
brain imaging modalities only produces a clearly observable
disease-related brain pattern when the disease has reached an
advanced stage. Also, abnormal patterns may not be specific
for a single brain disease. Functional imaging methods (PET,
fMRI) may give only a partial picture due to compensatory
mechanisms in patients with neuro-degenerative diseases. It
3
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is increasingly recognised that combining information derived
from different image modalities is essential for improvement
of the sensitivity and specificity of proposed biomarkers for
neuro-degenerative diseases [Davatzikos et al., 2008]. Another
shortcoming of current efforts is that only very few studies in
the literature report abnormal patterns for a given disease, so
that reproducibility of these findings is not yet firmly estab-
lished. Also, the typical size (10-20) of patient groups is too
small to differentiate between subtypes of a given disease (such
as akinetic-rigid versus tremor-dominant PD). It is clear that
progress in the early diagnosis of neuro-degenerative diseases
can only be made if both imaging and diagnostic data of large
numbers of patients in several phases of disease progression
are accumulated. Also, for the many MRI-based techniques
further improvements may be possible by optimising scanner
sequences for each modality, which therefore have to be care-
fully recorded for each scan session. This will require substan-
tial efforts in database formation during longitudinal studies
spanning several decades.
1.1 objective
The objective of this thesis is, first, to derive features from med-
ical imaging data in the hope to discover more sensitive and
specific biomarkers for the prediction of neuro-degenerative
diseases. Second, to develop supervised classification methods
for associating brain patterns (and features) extracted from
multi-modal brain imaging data to various types and stages of
neuro-degenerative diseases.
1.1.1 Specific Objectives
• To collect medical data and use it to identify structural
and functional brain patterns that display significant
differences between healthy subjects and patients with
neuro-degenerative diseases.
• To develop classification methods based on the brain
features extracted from the multi-modal brain images.
• To test the performance of the developed methods.
4
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1.2 techniques and tools
1.2.1 Imaging Data Acquisition by Positron Emission Tomography
In this thesis PET was used for image acquisition. PET is an
imaging technique that uses radioactive material to diagnose
diseases. The radiotracer is injected into a patient, where it
accumulates in the body to the specific part of interest. The
tracer emits positrons which are annihilated by electrons under
emission of gamma rays. The gamma rays are detected by a
device called a gamma camera. The device works with the com-
puter to measure the position-dependent amount of radiotracer
absorbed by the body, thus producing a brain image.
limitations of pet
• The scan session takes quite a long time (approximately
30 to 40 minutes [Carne et al., 2007]) in addition to time
reserved for the radiotracer (45 to 60 minutes [Townsend,
2004]) to accumulate in the body part of interest. The
duration of the whole scan process also depends on the
tissue under observation.
• The PET scan may show false results in case of chemical
imbalances in the body.
1.2.2 Analysis Tools
A number of analysis tools are briefly mentioned here for
completeness because they are used to pre-process the PET
brain images [Teune et al., 2013], but are not further discussed
in this thesis.
1.2.2.1 Statistical Parametric Mapping (SPM)
The SPM package [Friston et al., 2007] can be used to process
images for feature extraction. Processing of images can include
segmentation, co-registration and normalisation, all which are
found in the SPM package.
5
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1.2.2.2 Voxel Based Morphometry (VBM)
VBM is a very useful method to analyse images on the voxel
level Ashburner and Friston [2000]. For example, in the study
by Chételat et al. [2008], VBM was used to determine the differ-
ence in levels or stages of progression of NDs like Alzheimer’s.
VBM has also been used to differentiate several NDs based on
pathology. Burton et al. [2004] used VBM to study the pattern
of cerebral atrophy in PD in comparison to healthy controls,
AD and DLB; the result was that atrophy is greater in some
brain areas for AD than for PD. Generally VBM has been used
for differentiation of several NDs and their stages.
1.2.3 Classification Tools/Pattern classification
Supervised classification methods for associating brain patterns
to various forms of neuro-degenerative disease will be applied
to PET data in this thesis. By using a data set of subjects whose
diagnosis has been determined by medical experts, a classifier
is trained using the set of features in conjunction with subject
labels. After training, the classifier can be used to classify new
subjects for which their diagnosis is unknown. Extracted fea-
tures of the new subject are compared with the training set
features indirectly. That is to say, using the rules established
by the classifier during the training, the classifier computes the
best matching disease type(s). This procedure is visualised in
Figure 1.2. The training phase of the classification system is
shown on the left. The classification or query phase, shown
on the right, employs the same procedures, the features are
extracted from the test case(s) and used for classification. That
is, the label(s) of the test/query image(s) is determined.
An important requirement for this method to work is that the
number of training samples per disease (sub)type is sufficiently
high. As more training data become available in the course
of time the classifiers are expected to increase in classification
performance.
There are many different classification methods in neural-
network and statistical-decision theory. Within learning and
reasoning approaches, decision trees (DT) are among the most
popular ones [Breiman et al., 1984; Quinlan, 1993]. They are also
intuitive for non-experts, since the DT procedure corresponds
to the way humans perform classification based on many fea-
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Figure 1.2: Classification System: On the left is the training phase and
on the right is the testing phase.
tures (like in taxonomy). Therefore we start our investigations
with this classification method. After DT, we concentrate on
linear classifiers (with linear decision boundary) because more
complex systems (multilayered neural networks, SVM with
non-linear kernel etc.) might be at risk to over-fit the relatively
small datasets. Distance based methods such as Generalized
Matrix Learning Vector Quantization (GMLVQ) will be applied
and compared with the decision tree algorithms. Feature reduc-
tion/definition is an integral part of these methods [Schneider
et al., 2007]. Alternative classifiers such as the Support Vector
Machine (SVM) [Hammer et al., 2004] will be applied as well.
1.2.3.1 Decision trees
A decision tree represents a recursive partition of the instance
space [Rokach and Maimon, 2010]. It consists of at least a root
node which can be connected by successive edges to child
nodes. These child nodes, also known as internal nodes, are in
turn connected to child nodes, until the leaf nodes are reached
which do not have out-going edges. A new data example is
classified by going through a path from the root node to the leaf
node, while testing each feature of that example represented at
each of the internal nodes. Based on the outcome of each test,
a sequence of edges is followed until a leaf node is reached.
7
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Since each leaf carries a class label, the new data example is
assigned the class of the leaf it reaches. There are algorithms
that can be used to construct decision trees which include
C4.5 [Quinlan, 1993], CART Breiman et al. [1984] and others. In
particular, the C4.5 decision tree inducer uses an information
theoretic criterion to build decision trees. A dataset is split into
subsets at each node by choosing the attribute/feature that
maximizes the information gain. The details about information
gain are found in chapter 3. The optimal decision tree is the
one which minimizes the generalization error. Increased robust-
ness is provided by applying “bagging” [Breiman, 1996]. For
the problem considered here, i.e., brain images which would
require human interpretation, a decision tree-based approach is
very suitable, because it resembles the way that human experts
perform classification.
1.2.3.2 Generalized Matrix Learning Vector Quantization
GMLVQ estimates the relevance of features in their ability to
classify data. Then the classifier uses the weighted features
(according to their relevance) and class prototypes to separate
groups of data. This is possible with the full matrix Λ which
accounts for pairwise correlations of the feature dimensions.
A distance metric is used that has the form dΛ(wk,x) = (x−
wk)
TΛ(x−wk), where Λ is a positive semi-definite N × N
matrix which is used to quantify the dissimilarity of an input
vector x and the prototypes wk [Schneider et al., 2009].
1.2.3.3 Support Vector Machine
The Support vector machine determines the optimal hyper-
plane with the largest distance or margin between support
vectors (border-line training data examples) separating the in-
stances in the feature space. A new data example is classified
as belonging to either of the classes separated by the hyper-
plane. For example, given training data with input vectors
x1, x2, ..., xn ∈ Rd and labels y1, y2, ..., yn ∈ {−1,+1} [Oz and
Kaya, 2013], as shown in Figure 1.3, we need to find an optimal
hyperplane w · x + b = 0 (i.e., vector w and the scalar b) which
separates the negative data examples from the positive data
examples. There could exist a number of such hyperplanes, but
SVMs find the hyperplane that maximizes the gap between
the support vectors. This gap (as seen in Figure 1.3) is the
8
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distance between parallel hyperplanes w · x + b = −1 and
w · x + b = +1, i.e., 2||w|| . In order to maximize the gap we need
to minimize 12 ||w||2 under the following constraints:
w · xi + b ≤ −1 if yi = −1
w · xi + b ≥ +1 if yi = +1
Equivalently:
yi(w · xi + b) ≥ 1, i = 1, ..., n.
Generally, we want to maximize 2||w|| subject to yi(w · xi + b) ≥ 1
for i = 1, ..., n. Then given a new data example x, the decision
function is signum( f (x)), where f (x) = w · x + b, w ∈ Rd and
b ∈ R.
Figure 1.3: Linear SVM: The optimal hyperplane separating two
classes, i.e., red dots for the negative class and blue dots
for the positive class.
However, if the classes are not linearly separable, the large
margin concept has to be extended in order to tolerate misclas-




In addition to the pattern recognition algorithms, we will
also apply visualisation techniques such as scatter plot ma-
trices [Zheng et al., 2014], decision tree diagrams [Stiglic et al.,
2012], or multiple views [Wang Baldonado et al., 2000] to ex-
plore the labeled data sets in feature space. Visualisation meth-
ods will serve two important goals. First, they will give an
insight in the distribution of the data points in the feature
space, hence portraying an idea of how data can be separated
into distinct classes. Second, visualisation allows an intuitive
way to present the results to the medical experts, thereby facili-
tating communication.
1.3 ssm/pca method for feature extraction
The scaled subprofile model with principal component analysis
(SSM/PCA) [Moeller et al., 1987; Moeller and Strother, 1991]
is used in this thesis to extract patterns from PET data with
the removal of the group mean and the voxel mean, thereby
removing the overall major subject and group global effects be-
fore applying PCA to the data. This process makes evident the
main patterns of metabolic brain activity in the data. It is from
these patterns that the features to be used in the classification
process are determined.
In this thesis, the extracted features depend entirely on the
whole input dataset, since they are produced by PCA. This
makes the leave-one-out method used for performance evalu-
ation more complicated than usual. In other words, since the
features are dependent on the input data, for each leave-one-
out run, a test subject is always removed from the training
set before applying the SSM/PCA method and later projected
onto the extracted patterns (from the training set) to obtain its
scores.
1.4 thesis contribution and content
Machine learning methods are employed in the classification
of neurodegenerative diseases. In chapter 2, which is based
on [Mudali et al., 2015], we look at the classification of parkin-
sonian syndromes since they are not easily separable. We used
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the C4.5 decision tree inducer [Quinlan, 1993] to train classifiers
on the subject scores as features extracted from FDG-PET data.
Having applied a different method called stepwise regression
(SR) [Teune et al., 2013] to the same parkinsonian syndromes
data, we studied the difference between this method and the
decision tree (DT) method. This is the topic of chapter 3, which
is based on [Mudali et al., 2016c].
Other classification methods were introduced in chapter 4
in the hope to improve classification accuracy. This chapter
is based on [Mudali et al., 2016b]. The GMLVQ and SVM
classifiers were trained using features extracted from the FDG-
PET data, similar to the method used in chapter 2 and chapter 3.
The same SSM/PCA method was applied to the FDG-PET
data to extract the features, specifically subject scores. These
subject scores were input to the GMLVQ and SVM classifiers
to determine the correct subject(s) label(s). Using leave-one-out
cross validation, the classifier performances were evaluated.
In chapter 5, which is based on [Mudali et al., 2016a], more
PD data consisting of later disease stage brain images was ac-
quired and combined with the early stage data. The three clas-
sification methods i.e., decision trees, GMLVQ and SVM, were
applied to combinations of the early and late-stage datasets.
Additionally, we interchanged the later and earlier disease stage
datasets for training and testing the classifiers.
Lastly, chapter 6 contains a summary of the thesis and possi-
bilities for future work.
11
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U S I N G D E C I S I O N T R E E S W I T H S S M / P C A
F E AT U R E S
abstract: Medical imaging techniques like fluorodeoxyglucose positron emission
tomography (FDG-PET) have been used to aid in the differential diagnosis of neu-
rodegenerative brain diseases. Visual Interpretation of FDG-PET scans and clinical
symptoms of patients with neurodegenerative brain diseases can be difficult, especially
at an early disease stage. In this study, the objective is to classify FDG-PET brain
scans of subjects with parkinsonian syndromes (Parkinson’s disease, Multiple System
Atrophy, and Progressive Supranuclear Palsy), compared to healthy controls. The
scaled subprofile model/principal component analysis (SSM/PCA) method was applied
to FDG PET brain image data to obtain covariance patterns and corresponding subject
scores. The latter were used as features for supervised classification by the C4.5 decision
tree method. Leave-one-out cross validation was applied to determine classifier perfor-
mance. We carried out a comparison with other types of classifiers. The performance of
the decision tree method is in some cases (somewhat) lower than that of other classifiers
like nearest neighbors or support vector machines. However, the big advantage of
decision tree classification is that the results are easy to understand by humans. A
visual representation of decision trees strongly supports the interpretation process,
which is very important in the context of medical diagnosis. Further improvements are
suggested based on enlarging the number of the training data, enhancing the decision
tree method by bagging, and adding additional features based on (f)MRI data.
Keywords: Parkinsonian syndromes, FDG-PET data, scaled subprofile model,
principal component analysis, decision tree classification, visual analysis.
2.1 introduction
Neurodegenerative brain diseases like Parkinson’s disease (PD),
multiple system atrophy (MSA), or progressive supranuclear
palsy (PSP), are difficult to diagnose at early disease stages
[Litvan et al., 2003]. It is important to develop neuroimag-
ing techniques that can differentiate among the various forms
of parkinsonian syndromes and stages in progression. Early
disease detection is aided by brain imaging techniques like
[18F]-fluorodeoxyglucose (FDG) positron emission tomography
13
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(PET) and magnetic resonance imaging (MRI), to obtain image
data and derive significant patterns of changed brain activity.
Several techniques have been developed to identify disease-
related network patterns of cerebral glucose metabolism.
Covariance techniques like principal component analysis
(PCA) can be used to extract significant patterns from brain
image data. PCA is known for its capability to identify patterns
in high-dimensional data like brain image data. A possible ap-
proach to biomarker identification is the scaled subprofile mod-
el/principal component analysis (SSM/PCA) method [Moeller
et al., 1987; Moeller and Strother, 1991]. SSM/PCA is a feature
extraction method which enhances identification of significant
patterns in multivariate imaging data. This method has been
extensively applied to positron emission tomography data to
identify brain patterns which display significant differences
between healthy controls and parkinsonian conditions. The
SSM/PCA method helps to reduce data dimensions and to re-
veal the brain patterns characteristic for a certain parkinsonian
syndrome. Resting state metabolic networks obtained from
FDG-PET scans were used to identify disease related metabolic
brain patterns of PD, MSA and PSP [Ma et al., 2007; Eckert
et al., 2008; Eidelberg, 2009; Teune et al., 2013]. In a previous
study by Tang et al. [2010], it was demonstrated that by using
an image-based classification routine, it was possible to distin-
guish with high specificity between PD and MSA/PSP, and in
a second step between MSA and PSP as compared to controls.
In a recent study of Hellwig et al. [2012], the diagnostic
accuracy of FDG-PET in discriminating parkinsonian patients
was investigated. FDG-PET scans were analyzed by visual
assessment including individual voxel based statistical maps
(a 3D stereotactic surface projection technique; 3D-SSP). These
studies compared only two classes at a time or on two levels
(healthy and patient group, or two patient groups). This puts
forward a research challenge to improve the SSM/PCA method,
to be able to distinguish different neurodegenerative brain
diseases from each other in one analysis.
For this reason we consider machine learning approaches
like decision-tree methods to be able to compare more than two
patient groups at the same time and possibly detect subtypes
within patient groups. The C4.5 decision tree classification
algorithm by Quinlan [1993] is used to classify parkinsonian
conditions from FDG-PET imaging data. This algorithm uses a
14
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feature selection criterion known as information gain to induce
decision trees from training data. The subject scores derived
from the SSM/PCA method are used as input features for the
C4.5 algorithm. After the training phase, the decision trees
can then be used as predictors for unseen cases with unknown
disease type. Decision trees are known to be intuitive and easily
understandable by humans [Cintra et al., 2012]. In other words,
they can be easily visualized and interpreted by the clinicians.
In this chapter, we combine the SSM/PCA method in a novel
way with the C4.5 decision tree classification algorithm which
classifies parkinsonian disorders according to their respective
disease types. We also compare the decision tree method with
a number of other classifiers with respect to different criteria,
such as performance and interpretability by humans.
2.2 materials and methods
The extraction of patterns and classification involves four main
steps: data acquisition, feature extraction, feature selection, and
classification, see Figure 2.4.
Figure 2.4: Classification steps.
2.2.1 Data Acquisition
FDG-PET scans from a previous study [Teune et al., 2010]
describing 18 healthy controls (HC), 20 PD, 21 MSA, and 17
PSP patients were used for the present analysis. At the time of
referral for imaging, the clinical diagnosis of most patients was
uncertain. The final clinical diagnoses according to established
clinical research criteria [Gilman et al., 2008; Litvan et al., 1996,
2003] were made after a follow-up time after scanning of 4±3
15
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years (y) in PD, 2±1y in MSA, and 3±2y in PSP. Included
PD patients were 9 male (M), 11 female (F), 6 right body-side
affected, 14 left-side affected, with mean age of 63±9y and
Disease Duration (DD) at scanning of 3±2 years. Fourteen
probable MSA, 7 possible MSA patients (10M, 11F, age 64±10y;
DD 4±2y), and 13 probable, 4 possible PSP patients (9M, 8F,
age 68±8y; DD 2±1y) were included.
2.2.2 Feature Extraction
We reimplemented the SSM/PCA method in Matlab based on
the description by Spetsieris and Eidelberg [Eidelberg, 2009;
Spetsieris et al., 2010; Spetsieris and Eidelberg, 2011; Spetsieris
et al., 2009]. First, the FDG-PET images are loaded in a data
matrix Psv, and a mask is applied to each subject image in
Psv (s [1,...,M] refers to subjects and the column index v refers
to voxels) to remove all voxels with intensity value less than
35% of the whole brain volume maximum. Then the subject
matrix is log-transformed and doubly centered to create a
subject residual profile (SRP) matrix SRPsv. PCA is then ap-
plied to the matrix SRPsv to obtain its eigenvectors. These
eigenvectors are called Group-Invariant Subprofile (GIS) pat-
terns (GISk, k = 1, 2, ..., M), and represent characteristic disease-
related brain patterns. Furthermore, subject scores are com-
puted as the contribution of each subject image to a disease
related pattern GISk.
Figure 2.5 illustrates the flow of the program. The main steps
of the method are as follows, see [Spetsieris and Eidelberg,
2011].
1. The FDG-PET images are loaded into a data matrix Psv 1
of dimension M × N, where the row index s (1,...,M)
refers to subjects, and the column index v refers to vox-
els. So row s contains the 3D image data for subject s,
reformatted in vector form.
2. A mask is applied to each subject image in Psv to reduce
low values and noise in the brain volumes. In this study,
all voxels with intensity value less than 35% of the whole
brain volume maximum were removed to create individ-
ual masks. Next a group mask with non-zero values for
1 By expressions like “the matrix Psv” we mean the matrix P with elements Psv.
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Figure 2.5: Computation flow chart illustrating SSM/PCA analysis.
For explanation see text.
all subjects is created by taking the intersection of the
individual masks.
3. The subject matrix Psv is log-transformed to obtain the
matrix LogPsv. This step is necessary in order to remove
multiplicative scaling effects.
4. The log-transformed subject matrix is doubly centered.
The mean across voxels (local glucose metabolic rate
LGMR) for each subject and the mean across subjects
(GMP image) is subtracted from the matrix LogPsv to
create a subject residual profile matrix SRPsv, i.e.,




Here meanvox is the mean across voxels per subject and
meansub is the mean across subjects per voxel. This dou-
ble centering is carried out in order to: 1) remove offset
differences per subject 2) remove offsets per voxel, i.e.,
enhance/retain differences between subjects per voxel;
removing uninformative overall behaviour.
5. PCA is applied to the matrix SRPsv. The eigenvectors
of the PCA analysis are called Group-Invariant Subpro-
file (GIS) patterns (GISk, k = 1, 2, ..., M), and represent
characteristic brain patterns.
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6. Subject scores are computed as the amount of expression
of a subject on a disease related pattern GISk. The score
of subject s for the kth GIS pattern is defined as the inner





The SSM/PCA method was applied to several data groups
(disease group(s) compared to healthy controls) in training
set(s) from which disease related patterns (GISk) were extracted
with positive and negative loadings (voxel weights) [Ma et al.,
2009]. The brain images from the training set are weighted onto
the patterns to obtain subject scores, which depict how much
each subject image contributes to a pattern.
Subject scores as features for classification
Features are usually derived as characteristics of an object such
as texture, color, or shape [Westenberg and Roerdink, 2002],
which can be computed for each subject (data set) separately.
The use of PCA-based subject scores as features deviates sig-
nificantly from the standard situation through the fact that
features now depend on the whole dataset. Also, the number
of features is, at least initially, equal to the number of principal
components which is equal to the number of data sets. So when
a subject is removed or added to the data collection the scores
of all the other subjects change as well. Therefore, there is need
to redo the SSM/PCA procedure once the dataset changes to
obtain new scores.
2.2.3 Decision tree classification
The C4.5 decision tree method [Quinlan, 1996b] is a supervised
learning strategy which builds a classifier from a set of training
samples with a list of features (or attributes) and a class label.
The algorithm splits a set of training samples into subsets such
that the data in each of the descending subsets are “purer” than
the data in the parent subset (based on the concept of informa-
tion gain from information theory). Each split is based on an
optimal threshold value of a single feature. The result is a tree
in which each leaf carries a class name and each interior node
specifies a test on a particular feature. The tree constructed in
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the training phase of a decision tree classifier can be drawn in
an easy to understand graphical representation which shows
the successive features and threshold values which the algo-
rithm has used to separate the data set in non-overlapping
classes. Once a tree has been obtained from the training sam-
ples, it can be used for testing to classify unseen cases where
the class label is unknown.
The C4.5 decision tree algorithm [Quinlan, 1993] has been
used in many previous studies, ranging from diatom identifi-
cation [du Buf and Bayer, 2002] to classification of anomalous
and normal activities in a computer network to curb intru-
sions [Muniyandi et al., 2012]. The method has also been ap-
plied to improve accuracy in multi-class classification problems.
For example, Polat and Günes¸ [2009] applied a novel hybrid
classification system based on the C4.5 decision tree classifier
and a one-against-all approach, obtaining promising results.
In addition, Ture et al. [2009] analysed several decision tree
methods (CHAID, CART, QUEST, C4.5, and ID3) together with
Kaplan-Meier estimates to investigate their predictive power
of recurrence-free survival in breast cancer patients, they re-
port that C4.5 performed slightly better than other methods.
In summary, decision trees are considered to be powerful for
classification and are easy to interpret by humans. Not only are
they simple and effective, but they also work well with large
datasets [Perner, 2001].
decision tree classification of parkinsonian syn-
dromes Using the C4.5 machine learning algorithm, we
trained classifiers on subject scores of extracted patterns for
healthy subjects and subjects with known types of neuro-
degenerative disease. The result is a pruned decision tree show-
ing classified subject images. The goal of pruning is to obtain a
tree that does not overfit cases. Note that it would be possible
to obtain 100% correct classification in the training phase by
using a less stringent pruning strategy. However, this would
come at the expense of generalization power on unseen cases.
In contrast to applications of the SSM/PCA method which
make a pre-selection of principal components (GIS vectors)
on which the classification will be based, the C4.5 algorithm
uses all principal components and the corresponding subject
scores as input. The algorithm itself determines which principal
components are most discriminative to separate the data set
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into classes. More discriminative components appear higher
in the decision tree, i.e., closer to the root; refer to Figure 2.6
for an example, where the subject score SSPC5 is the most
discriminative feature.
In order to apply the C4.5 classifier to unseen cases, the re-
quired subject scores for testing are first computed by projecting
the SRP of the new subject on the GIS profiles of the training
set according to Eq. (2.1). The computation of the SRP for the
unseen case involves centering along the subject dimension, i.e.,
subtracting the GMP (group mean profile). The assumption is
that this GMP can be obtained from the reference group only,
i.e., the group used for training the classifier; see the discussion
in Spetsieris et al. [2009], [p. 1244].
2.2.4 Other Classifiers
We also applied a number of other classifiers: nearest neighbors;
linear classifiers: linear discriminant analysis and support vec-
tor machines; random forests, which is an extension of decision
trees; classification and regression trees (CART) for predicting
real/continuous variables; and naive Bayes, a probabilistic clas-
sifier. Linear classifiers in particular are simple to implement.
They are known to work better in situations where the data is
uniformly distributed with equal covariance.
nearest neighbors (nn) NN is a classification method
which assigns a class to a new data point based on the class
of the nearest training data point(s). In the K-NN (K-Nearest
Neighbors) method, distances to the neighbors are computed
first. Then, a new data point receives the majority label of the
K nearest data points.
linear discriminant analysis (lda) LDA, like PCA,
is used for data classification and dimensionality reduction.
This classifier maximizes the between-class variance and mini-
mizes the within-class variance to ensure a clear separation in
datasets. Accordingly, the training data are first transformed,
then the data in the transformed space are classified as belong-
ing to a class which minimizes the Euclidean distance of its
mean to the transformed data [Fukunaga, 1990].
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support vector machine (svm) SVM performs classifi-
cation by generating an optimal decision boundary in the form
of a hyperplane which separates different classes of data points
in the feature space. The decision boundary should maximize
the distance between the hyperplane and support vectors called
the margin [Duda et al., 2000].
random forests Random Forests is a machine learning
method for classification of objects based on a majority vote of
a multitude of decision trees. This method combines bagging
(random selection of cases) and random selection of features
(at each node) during the training phase. Also, the trees are not
pruned.
classification and regression trees (cart) CART,
just like C4.5, is a decision tree learning method. However, in
addition to using decision trees as predictors, CART includes
regression trees for predicting continuous variables.
naive bayes This is a method that classifies data points
based on their likelihood and the prior probabilities of occur-
rences of known classes. The final classification is achieved
by combining the prior and the likelihood to form a posterior
probability using Bayes’ rule. Overall, the new data will belong
to a class which maximizes the posterior probability.
2.3 results and discussion
2.3.1 Results for decision tree classifiers
Decision tree classifiers were trained by applying the C4.5
algorithm to individual (each disease group versus healthy
controls) and combined datasets of PD, PSP, MSA patients
and healthy controls (HC) with known class labels, as listed in
Section 2.2.1. For the individual datasets, we were interested
in identifying features which best separate two groups (i.e., a
disease group from healthy controls). For the combined datasets
we compared all the groups, that is, PD, MSA, PSP, and HC
to each other to obtain feature(s) which can separate the four
groups. Tree pruning was carried out by using the default
values of the C4.5 algorithm [Quinlan, 1993].
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2.3.1.1 Building classifiers for individual datasets
Decision tree classifiers were built in the training phase from
the individual datasets (PD, PSP, MSA) compared to the HC
group of 18 subjects.
pd group The decision tree built from the PD-HC dataset
(18 healthy and 20 PD subjects) is illustrated in Figure 2.6.
The subject scores derived from 38 principal components (GIS
vectors) are the attributes on which decisions are made. They
are represented as oval-shaped interior nodes in the tree. Next
to the arrows the threshold values are shown that were used
to split the dataset. Likewise, the leaf nodes, represented as
rectangles, show the final class or decision made at that level
of the tree (for example, PD or HC in Figure 2.6). Red and blue
colors are used to indicate cases labeled as PD and healthy,
respectively. The numbers between brackets in the rectangles
show the total number of cases classified at that leaf. Addi-
tionally, the number after the slash (if present) represents the
number of misclassified cases at that leaf.
Figure 2.6: The decision tree built from the PD-HC dataset. Oval-
shaped interior nodes: features (subject scores) used to
split the data. Threshold values are shown next to the ar-
rows. Rectangular leaf nodes: the final class labels (red=PD,
blue=HC).
As can be seen in Figure 2.6, the classifier chooses the subject
score based on component 5 (SSPC5) to make the first split.
In the right subtree, nine PD subjects > 254.14 are identified.
The classifier goes on to test the rest of the subjects based on
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Figure 2.7: The decision trees built from the MSA-HC (left) and PSP-
HC (right) datasets. For details, refer to Fig. 2.6.
component 26, where nine subjects (subject score > 29.684) are
identified as HC; etc. Only one PD subject is misclassified as
HC, as can be seen in Figure 2.6 in the lower-left rectangle.
msa group The decision tree built from the MSA-HC dataset
(18 healthy and 21 MSA subjects) is illustrated in Figure 2.7
(left). The attributes are subject scores derived from 39 principal
components. Again, one HC subject is misclassified
psp group The decision tree built from the PSP-HC dataset
(18 healthy and 17 PSP subjects) is illustrated in Figure 2.7
(right). The attributes are subject scores derived from 35 princi-
pal components.
2.3.1.2 Building classifiers on combined datasets
We also applied the C4.5 classification algorithm to the com-
bined datasets consisting of all four groups. Therefore, the
dataset consisted of 76 subjects, 18 HC, 20 PD, 21 MSA and 17
PSP. Subject scores were obtained by applying the SSM/PCA
method to the combined group. The resulting decision tree
is shown in Figure 2.8. Three PSP subjects are classified erro-
neously, two as PD and one as MSA.
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Figure 2.8: The decision tree built from the combined PD-PSP-MSA-
HC dataset.
2.3.1.3 Leave-one-out cross validation
In leave-one-out cross-validation (LOOCV), a single observation
from the original dataset is used as the validation set (also
known as test set) and the remaining observations form the
training set. This procedure is repeated N times where each
observation is used once as a validation set.
The LOOCV method was applied to individual and com-
bined datasets, i.e., PD-HC, MSA-HC, PSP-HC, and the com-
bined dataset PD-MSA-PSP-HC to estimate classifier perfor-
mance on unseen cases. Here performance is defined as the
percentage of correct classifications over the N repetitions. To
ensure that attributes of the training set, and thus the trained
classifier, are independent of the validation sample, the test
subject was removed from the initial dataset before applying
the SSM/PCA method to the training set (with N − 1 samples)
for obtaining the subject scores needed to train the C4.5 deci-
sion tree classifier. The classifier was then used to determine
the label for the test subject. This procedure was applied for
each of the N subjects in the original dataset. Table 2.1 shows
the classifier performance.
As seen in Table 2.1, the C4.5 classifier performs highest with
the PSP group at 80% and lowest with the PD group at 47.4%.
The feature at the root of a decision tree is most significant
in classification, since it has the highest information gain (see
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Table 2.1: Classifier performance for the different data sets (patients vs
healthy controls, number of cases in brackets) in the LOOCV,
without feature pre-selection. The column Perf.(%) indicates
the percentage of subject cases correctly classified per group,
Sensitivity (%) the percentage of correctly classified patients
and Specificity (%) the percentage of correctly classified
healthy controls.
Feature set(size) Perf. (%) Sensitivity (%) Specificity (%)
PD-HC (38) 47.4 45 50
MSA-HC (39) 71.8 61.9 83.3
PSP-HC (35) 80.0 82.4 77.8
Section 2.2.3). As seen in Figure 2.7, feature 1 (i.e., the subject
score on principal component 1) is chosen by the classifier
in making a first separation between healthy and PSP/MSA
subjects. Moreover, we observed that for the PSP-HC group
feature 1 occurs as the root for all LOOCV trees. This behaviour
is strongly linked to the high performance for the PSP group,
since the classifier is utilizing the relevant feature(s) for the
separation of the groups.
The MSA-HC dataset has the second best performance and
we observed that the feature at the root of the MSA-HC tree
in Figure 2.7 (left) also appears as root in 32 out of 39 trees in
LOOCV. On the contrary, for the PD group, different features
were chosen by the classifier as root nodes of the different
LOOCV trees. Apparently, the different features contain only
weakly relevant information to separate the healthy group
from the PD group. In this case, application of the decision tree
method with all features included leads to a form of over-fitting.
We attribute this to the fact that the PD group is quite similar
to the HC group, at least with respect to the features we have
measured. The early PD group might contain other disease
sub-types which need to be identified.
For the combined dataset (see Figure 2.8), feature 3 occurs
as the root node, so is the best at separating the four groups
(HC, PD, MSA, and PSP). Furthermore, the same feature oc-
curs as the root node in 63 out of 76 LOOCV trees, implying
consistency of the classifier. However, the performance for the
combined group is low, i.e., 53.9% (the number of correctly
classified healthy controls, PD, PSP, and MSA subjects is equal
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to 55.6%, 35%, 58.5%, and 66.7%, respectively). Our explana-
tion is that the number of subjects per class is quite low given
the large variability in each group. In addition, the combined
group is not well balanced in view of a relatively small size of
the healthy subject group versus the combination of the three
disease groups.
permutation test In order to determine the significance
of the performance results we ran a permutation test on the
PD-HC, MSA-HC, and PSP-HC groups [Al-Rawi and Cunha,
2012; Golland and Fischl, 2003]. The steps of the procedure are:
1. for each group, perform a LOOCV on the original subject
labels to obtain a performance PO;
2. repeatedly permute the labels and then do a LOOCV
to obtain performances Pi for i = 1, . . . , Nperm (we used
Nperm = 100)
3. compute the p-value as the total number of all Pi greater
or equal to PO, divided by Nperm.
If p < 0.05 the original LOOCV result is considered to be
statistically significant.
The results of the permutation test were as follows. For the
PSP-HC group: p = 0.00; for the MSA-HC group: p = 0.01;
for the PD-HC group: p = 0.62. So we can conclude that for
the PSP-HC and MSA-HC groups the performance results are
significant. However, for the PD-HC group this is not the case.
This is consistent with the lack of robustness of the LOOCV
trees we already noted above. The healthy and PD group are
very similar and hard to separate, given the small number of
datasets.
2.3.1.4 Pre-selection of features
In the hope to improve the classifier performance, we varied the
number of features used to build the classifier in the LOOCV.
This was done in two different ways: (i) by choosing the sub-
ject scores of the n best principal components according to
the Akaike Information Criterion (AIC) [Akaike, 1974]; (ii) by
choosing the first n principal components arranged in order
of highest to lowest amount of variance accounted for. The
classifier performance at the varying numbers of features is
shown in Table 2.2.
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Table 2.2: Classifier performance with pre-selection of features (pa-
tients vs healthy controls, number of cases in brackets). The
percentage of principal components arranged in order of
highest to lowest variance accounted for, and best number
of PCs according to AIC. Highest performances in bold.
In order of amount of variance According to AIC
% / no of PCs 3% 5% 50% 70% 100% 1 3 5
PD-HC (38) 55.3 63.2 57.9 63.2 47.4 63.2 50 47.4
MSA-HC (39) 71.8 74.4 69.2 71.8 71.8 66.7 69.2 74.4
PSP-HC (35) 82.9 80 77.1 77.1 80 82.9 80 80
As shown in Table 2.2, the performance for the PD group
improves from 47.4% to 63.2% when the number of features
is reduced from 100% to 70% and 5%. Also the performance
improves when only one best feature according to AIC is used
to build the classifier. Likewise the performance for the MSA
and PSP groups improve from 71.8% to 74.4% and 80% to
82.9%, respectively, when the number of features are reduced.
Notable is that the number of features at which distinct groups
perform best may differ. Specifically, when using the AIC for
pre-selection, not always one feature is good enough to separate
groups. This can be seen for the MSA group where five best
features were required to obtain the best performance. Overall,
pre-selection/reduction of features to include relevant features
can boost classifier performance.
2.3.1.5 Disease groups versus each other
Disease groups were compared to each other in a binary classi-
fication. That is to say, the PD group of 20 subjects versus the
MSA group of 21 subjects, PD group of 20 versus PSP group of
17 and MSA group of 20 vs PSP group of 17.
As seen in Table 2.3, PD vs MSA has the highest performance
with a relatively high sensitivity and specificity, consequently
PD can be separated rather well from MSA. For the PD vs PSP
and MSA vs PSP groups the performance is slightly lower. The
performance for all groups slightly increases when features
are reduced to only 5 according to AIC. In spite of the high
performance of the PSP group versus the healthy group as seen
in Table 2.1, PSP performs relatively low when compared to
the other disease groups (PD and MSA). Apparently, the PSP
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Table 2.3: Performance for binary classification of disease groups in
the LOOCV. The number of cases per group are in brackets.
The column Perf. indicates the percentage of subject cases
correctly classified (all features included), Sensitivity the
percentage of correctly classified first disease group, Speci-
ficity the percentage of correctly classified second disease
group, and Perf. (AIC-5) the performance when features are
reduced to the best 5 PCs according to AIC.
Group Perf. (%) Sensitivity Specificity Perf. (AIC-5) (%)
PD vs MSA (41) 73.2 70 76.2 78
PD vs PSP (37) 67.6 80 52.9 70.3
MSA vs PSP (38) 68.4 76.2 58.8 71.1
features look more like those of PD or MSA patients than those
of healthy controls.
2.3.1.6 Combined disease groups
Our main interest is to distinguish the Parkinsonian syndromes
from each other. Therefore, we combined all disease groups
(i.e., PD, PSP, and MSA) without the healthy controls in a de-
cision tree multi-classification and applied LOOCV (at 100%
features used). The performance of the classifier is 65.5%, with
75% correctly classified PD subjects, 47.1% correctly classified
PSP subjects, and 71.4% correctly classified MSA subjects. Al-
together the PSP group has the lowest number of correctly
classified subjects, in agreement with the previous observation
that it contains similarities to PD and MSA. Figure 2.9 shows
the decision tree diagram obtained after training the classifier
with all features. Only one PD subject is misclassified as PSP.
varying the number of features for classification
Several LOOCV experiments were carried out while varying
the number of features used to build the classifier. The highest
performance was achieved when including 25% of all features.
Results for 100, 50, and 25% of all features are shown in Ta-
ble 2.4.
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Figure 2.9: The decision tree built from the disease groups compared
to each other i.e., PD-PSP-MSA dataset.
Table 2.4: Performance for binary classification of disease groups
(number of cases in brackets) in the LOOCV with feature
pre-selection. The columns Feat. and Perf. indicate the per-
centage of features used and the corresponding performance.
The remaining columns show confusion matrices and class
accuracies. The number of subjects correctly classified for
each class is in bold.
Feat. % Perf. % Class PD (20) PSP (17) MSA (21)
100 65.5 PD 15 5 3
PSP 4 8 3
MSA 1 4 15
accuracy 75 47.1 71.4
50 67.2 PD 15 5 2
PSP 4 9 4
MSA 1 3 15
accuracy 75 52.9 71.4
25 69 PD 15 5 2
PSP 4 9 3
MSA 1 3 16
accuracy 75 52.9 76.2
2.3.2 Results for other classifiers
We used ’scikit-learn’ [Pedregosa et al., 2011], a software pack-
age that includes a variety of machine learning algorithms, to
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obtain classification results for a number of other classifiers.
The classifiers used were described in Section 2.2.4. In principle,
we should test on subject scores obtained from the leave-one-
out method before applying the SSM/PCA method. However,
this would lead to a very time-consuming procedure. Since our
goal is to obtain an impression of the improvements possible by
using other classifiers, we instead applied LOOCV on subject
scores obtained from applying the SSM/PCA method to the
whole training set (all subjects included).
Performances for the PD, MSA, and PSP groups vs healthy
controls are shown in Table 2.5. No pre-selection of features
was applied.
Table 2.5: The LOOCV Performance for various types of classifier.
Features used were the subject scores obtained after apply-
ing the SSM/PCA method on all subjects included in the
datasets. (*) Note that for LDA only 90% of the features
were considered because of the classifier’s restrictions while
constructing the covariance matrix. For easy reference, the
feature pre-selection results for C4.5 already presented in
Table 2.2 are included.
Dataset PD-HC MSA-HC PSP-HC
Nearest Neighbors 76.3 76.9 80.0
Linear SVM 78.9 92.3 88.6
Random Forest 63.2 61.5 71.4
Naive Bayes 65.8 71.8 71.4
LDA (*) 50.0 61.5 65.7
CART 57.9 53.8 85.7
C4.5 63.2 74.4 82.9
2.3.3 Discussion
The LOOCV performance as shown in Table 2.5 is highest for
the SVM and NN classifiers. These classifiers perform better
than C4.5, especially for the PD-HC group. We attribute this to
the fact that SVM and NN only have one decision boundary. On
the other hand, C4.5 has several decision boundaries, one for
each internal node of the decision tree. Thus a subject is tested
more than once and may become vulnerable to misclassification
in the case where the features depict noise or are irrelevant.
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CART is quite similar to C4.5; for the PD and PSP groups it has
a higher performance, but for MSA it is considerably lower.
Decision tree methods are faced with the problem of overfit-
ting, which causes all training cases to be correctly classified
but with limited generalizability. That is, the learned tree tends
to be so perfect that it is prone to misclassify unseen cases.
Also, providing many features to the decision tree inducer can
cause a low performance due to irrelevant and redundant fea-
tures, especially when the number of subjects is relatively small.
Moreover it has been observed that C4.5’s feature selection strat-
egy is not optimal, so having irrelevant and correlated features
can degrade the performance of the classifier [Perner, 2001]. In
addition, the C4.5 classifier has been reported to perform lower
when it comes to continuous attributes, which is the case in
our study (as subject scores are continuous) [Quinlan, 1996a].
However, with pre-selection of features and pruning decision
trees after construction, these problems can be reduced. Indeed,
we found an increase in performance, especially for the PD-HC
group (see Table 2.2).
When the number of subjects in the training set is large
enough, the decision tree classifier will be capable to perform
sub-type classification of parkinsonian syndromes. Another
important advantage of the decision tree method over most
other methods is that it provides an intuitive way to get insight
in the behavior of the classification algorithm to physicians.
Drawings of decision trees are human understandable, and the
way a decision tree algorithm takes repeated decisions with
respect to multiple criteria is close to the way humans carry
out multi-criteria decision making. Likewise, the significance of
a particular feature is recognizable from the level in which the
corresponding node appears in the constructed tree. Therefore,
we have the opportunity to use human intelligence in the deci-
sion tree method to select those features (i.e., the corresponding
disease related patterns) that best distinguish between healthy
subjects and patients.
2.4 conclusions
Using the SSM/PCA method, Group-Invariant Subprofile (GIS)
patterns were extracted from FDG-PET data of patients with
three distinct groups of syndromes, i.e., Parkinson’s disease
(PD), multiple system atrophy (MSA), and progressive supranu-
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clear palsy (PSP), always compared to a healthy control (HC)
group. The subject scores corresponding to these patterns
served as the feature set for the C4.5 decision tree classifi-
cation algorithm. Classifiers were constructed for future pre-
diction of unseen subject images. Validation of classifiers to
ensure optimal results was performed using the leave-one-out
cross-validation (LOOCV) method. A permutation test was
performed to assess the statistical significance of the results.
We also compared the C4.5 classifier to various other classi-
fication algorithms, i.e., Nearest Neighbors, Linear SVM, Ran-
dom Forest, Naive Bayes, LDA, and CART. Of all classifiers,
the performance of Nearest Neighbors and Linear SVM was
highest. We found that most classifiers perform relatively well
for the PSP-HC and MSA-HC groups, but less well for the
PD-HC group. This may be closely linked to the fact that the
FDG-PET activation pattern of (early stage) PD patients is close
to that of normal subjects, whereas there is one distinctive fea-
ture which is present in MSA (low uptake in putamen) and
PSP (low frontal uptake), respectively, and absent in controls.
In clinical practice, the main problem is not so much to dis-
tinguish patients with parkinsonian syndromes from healthy
controls, but to distinguish between the different parkinsonian
diease types. For this reason, we also compared disease groups
to each other in a binary classification, with promising results:
in this case classifier performance was significantly higher, also
when the PD group was involved. In a recent study, Garraux
et al. [2013] used Relevance Vector Machine (RVM) to classify
120 parkinsonian patients on the basis of either binary classi-
fication (a single class of 3 atypical parkinsonian syndromes
[APS] versus PD), or multiple classification (PD and the 3 APS
separately versus each other). The performance achieved in the
study of Garraux et al. was higher than in ours. Note, how-
ever, that they had a larger dataset and incorporated bootstrap
aggregation (bagging) to boost the performance. We plan to
incorporate bagging in future work to improve classifier per-
formance.
To achieve high-quality biomarker identification, one needs
to accumulate large numbers of patient data in several phases
of disease progression. This is what we are currently pursu-
ing in the GLIMPS project [Teune et al., 2012], which aims
at establishing a national database of FDG-PET scans in the
Netherlands. Additionally, data could be generated from other
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imaging modalities such as (f)MRI, ASL, and DTI, to enable
the collection of a broad set of brain features needed for distin-
guishing the different disease types.
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3C O M PA R I S O N O F D E C I S I O N T R E E A N D
S T E P W I S E R E G R E S S I O N M E T H O D S I N
C L A S S I F I C AT I O N O F F D G - P E T B R A I N D ATA
U S I N G S S M / P C A F E AT U R E S
abstract:
Objective: To compare the stepwise regression (SR) method and the decision tree
(DT) method for classification of parkinsonian syndromes.
Method: We applied the scaled subprofile model/principal component analysis
(SSM/PCA) method to FDG-PET brain image data to obtain covariance patterns and
the corresponding subject scores. The subject scores were inputs to the C4.5 decision
tree algorithm to classify the subject brain images. For the SR method, the scatter plots
and receiver operating characteristic (ROC) curves show the subject classifications. We
then compare the decision tree classifier results with those of the SR method.
Results: We found out that the SR method performs slightly better than the DT.
We attribute this to the fact that the SR method uses a linear combination of the best
features to form one robust feature, unlike the DT method. However, when the same
robust feature is used as input to the DT classifier, the performance is as high as that of
the SR method.
Conclusion: Even though the SR method performs better than the DT method,
including the SR procedure in the DT classification yields a better performance.
Additionally, the decision tree approach is more suitable for human interpretation and
exploration than the SR method.
Keywords: Parkinsonian syndromes, FDG-PET data, scaled subprofile model,
principal component analysis, decision tree classification, stepwise regression.
3.1 introduction
Parkinsonian syndromes like other neurodegenerative diseases
are not easy to diagnose and distinguish at an early stage [Spet-
sieris et al., 2009; Wu et al., 2013]. With the intention to classify
these syndromes, the scaled subprofile model/principal com-
ponent analysis (SSM/PCA) method as explained by Moeller
et al. [1987] is used to extract disease-related metabolic brain
patterns in the form of principal component images from sub-
ject brain images. Then individual subject images are projected
onto the patterns to obtain their corresponding scores. These
scores depict the network expression of individual subjects on
the pattern [Fukunda et al., 2001].
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The SSM/PCA method has been used in several studies to
extract disease-related patterns from imaging data. In Moeller
et al. [1996], the SSM method is applied to regional metabolic
rates for glucose data to identify specific age-related disease
profiles. Similarly, in Spetsieris et al. [2009] the SSM/PCA
method is used to derive disease-related spatial covariance
patterns which are represented as spatial weighted images. In
the study by Spetsieris and Eidelberg [2011] the methodological
questions that arise regarding the use of the SSM method are
addressed. In addition, the SSM/PCA method together with
several versions of the Statistical Parametric Mapping (SPM)
software were applied by Peng et al. [2014] to obtain disease-
specific patterns. Therefore, from the aforementioned studies
we can say that the SSM/PCA method application is quite
broad and effective at identifying brain patterns. These pat-
terns are promising as biomarkers for predicting Parkinsonian
disorders and neurodegenerative diseases in general.
This chapter presents a comparison between the stepwise
regression (SR) method [Teune et al., 2013] and the decision tree
(DT) method in the classification of parkinsonian syndromes,
following previous work [Mudali et al., 2015]. In both methods
we apply the SSM/PCA method to the brain data to obtain
subject scores as features. Specifically, we use the C4.5 machine
learning algorithm in this study to build the DT classifiers
[Quinlan, 1993, 1996b; Polat and Günes¸, 2009]. The SR method
uses a mechanism of choosing one or a few models (here known
as components) from a larger set of models [Johnsson, 1992;
Thompson, 1995]. Further, the components are chosen based on
how well they separate subject image groups using the Akaike
information criterion (AIC) [Akaike, 1974].
There are three approaches we use in this study:
1. the stepwise regression (SR) method
2. decision tree classification with all features, and a reduced
set of features, respectively
3. decision tree classification using the set of features obtained
from the SR procedure.
With the SR method, one feature (subject z-score) is determined
from a combination of components, while in the DT method
several features (subject scores) are determined from individual
components. In approach 3 we combine the SR procedure
and decision tree method in two different ways. In the first
approach, the best features obtained by the stepwise procedure
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are used as features for decision tree classification, that is,
without linearly combining them. In the second approach, we
use the exact same subject z-score (that is, a linear combination
of best features) as obtained by the SR method (stepwise plus
logistic regression procedure) and use it as a single feature for
decision tree classification.
3.2 method
3.2.1 Data acquisition and feature extraction
We used fluorodeoxyglucose positron emission tomography
(FDG-PET) brain scans as described in the previous studies
by Teune et al. [2010, 2013]. The data set includes a total of
76 subject brain images, namely: 18 healthy controls (HC), 20
Parkinson’s disease (PD), 21 multi-system atrophy (MSA), and
17 progressive supra-nuclear palsy (PSP). An implementation of
the SSM/PCA method developed in Matlab was used following
the procedure as described by Eidelberg [2009]; Spetsieris et al.
[2009, 2010]; Spetsieris and Eidelberg [2011].
The SSM/PCA method was applied to the FDG-PET data to
obtain principal components (PCs) onto which original images
were projected to obtain their weights on the PCs, known as
subject scores. Thereafter, we used the subject scores as fea-
tures for the decision tree method and the stepwise regression
procedure to differentiate among the parkinsonian syndromes.
3.2.2 Classification
3.2.2.1 Stepwise regression method
Following Teune et al. [2013], the SR procedure is used to
obtain a linear combination of PCs (combined pattern) that best
discriminates groups. The SR method is as follows:
• The principal components that make up 50% of the vari-
ance are considered in the stepwise regression proce-
dure. This procedure retains only those which best sepa-
rate groups according to Akaike’s information criterion
(AIC) [Akaike, 1974].
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• By fitting the subject scores corresponding to the retained
PCs to a logistic regression model, scaling factors for all
PCs are obtained. The combined pattern is a sum of PCs
weighted by the scaling factors. Then the subject score
on the combined pattern is determined by adding the
retained subject scores multiplied by their corresponding
scaling parameters.
• Z-scores are calculated and displayed on scatter plots
and receiver operating characteristic (ROC) curves are
determined. Then a subject is classified according to the
z-score cut-off value, which corresponds to the z-score
where the sum of sensitivity and specificity is maximised.
A subject is diagnosed as a patient if the z-score value is
higher than the cut-off value and as a healthy control if it
is lower than the cut-off value.
leave one out cross validation (loocv) When us-
ing the SSM/PCA-SR method, one subject (for testing) is re-
moved from the training set at a time and the SSM/PCA
method is applied to the remainder of the subjects. The step-
wise regression procedure is followed to create a combined
pattern. The left-out subject scores on the PCs that form the
combined pattern are multiplied by the scaling parameters to
obtain a single subject score on the combined pattern. Each
subject score is transformed into a z-score which then becomes
the feature used to separate groups.
3.2.2.2 Decision tree method
This method builds a classifier from a set of training samples
with a list of features and class labels. We used the C4.5 machine
learning algorithm by Quinlan [1996b] to train classifiers based
on the subject scores as features. As a result, a pruned decision
tree showing classified subject images is generated. Pruning
helps to obtain a tree which does not overfit cases. Important
to note is that with the decision tree method, the principal
components are not combined but instead used individually.
Therefore, the DT method uses several features (subject scores




leave one out cross validation We placed one sub-
ject into a test set and the rest into a training set. Then the
SSM/PCA method was applied to the training set to obtain
subject scores. These subject scores were used to train the clas-
sifier and the test subject was used to test the DT classifier
performance. The procedure was repeated for each subject in
the dataset. We used AIC in conjunction with the SR procedure
to pre-select features for the DT method for improving the
classifier performance. Further, we provided the one combined
feature from the SR method as input to the DT method.
3.3 results
3.3.1 Stepwise Regression Procedure
The z-score scatter plots of the combined pattern and the ROC
curves are illustrated in Figure 3.10. For the scatter plots, the
groups are displayed on the X-axis and the z-scores on the
Y-axis. On the ROC curves the bullet (•) represents the cut-
point where the difference between true positive rate and false
positive rate, or Youden index [Youden, 1950], is maximised.
Note that the Youden index is equal to sensitivity+specificity-1
(see appendix 3.A). These results are similar to those in Teune
et al. [2013]. The only difference is seen in Figure 3.10(a), where
the cut-off is 0.36 instead of 0.45. This can be explained by the
fact that at both cut-off points the sensitivity and specificity are
the same; in this case 0.36 is chosen being the first z-score value
in ascending order.
3.3.2 Decision tree classifiers for disease groups versus the healthy
group
The decision tree classifiers are built from the disease datasets
(PD, PSP, MSA) all compared to the healthy control (HC) group
of 18 subjects. Figures 3.11 and 3.12 show the decision tree
diagrams and corresponding scatter plots. The internal tree
nodes are drawn as oval shapes corresponding to the attributes
(subject scores) on which decisions are made, with the thresh-
old values for splitting the dataset indicated next to the lines
connecting two internal nodes. The actual class labels are rep-
resented in the rectangles (leaves), where 1 is the label for
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Figure 3.10: Scatter plots and ROC curves for subject z-scores. (a): PD
vs HC; (b): MSA vs HC; (c): PSP vs HC.
the disease group (PD, PSP, or MSA) and 0 the label for the
healthy group (HC). In addition, the numbers in the brackets
of the rectangles show the total number of subjects that are
classified at that leaf, with a fraction indicating the number of
misclassifications as the denominator.
3.3.2.1 PD Group
The output of the decision tree method applied to the PD-HC
dataset (18 healthy and 20 PD) is illustrated in Figure 3.11.
The attributes are subject scores derived from 38 principal
components.
As can be seen in Figure 3.11, the classifier chooses the subject
score based on component number 5 (SSPC5) to make the first
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Figure 3.11: The decision tree diagram and the scatter plot showing
the distribution of the subject scores of the chosen PCs by
the decision tree classifier, without feature pre-selection.
split of the dataset. As a result, nine PD subjects (feature value
> 254.14) are identified. The classifier then uses component
number 26 to separate the rest of the subjects, where nine
subjects (feature value <= -32.241) are identified as HC; etc.
Only one PD subject is misclassified as HC. Looking at the
scatter plots on the right of Figure 3.11, we can clearly see that
for the chosen PCs there is no clear separation between PD and
healthy controls.
3.3.2.2 MSA and PSP Groups
Figure 3.12 shows the decision trees and the distribution of
subject scores displayed on scatter plots for the MSA-HC (18
HC and 21 MSA) and PSP-HC (18 HC and 17 PSP) datasets.
The attributes are subject scores derived from 39 and 35 princi-
pal components for MSA and PSP, respectively. For the MSA
group, one HC subject is misclassified whereas no subject is
misclassified for the PSP group. Also, important to note is
that for the PSP group the classifier chooses only 2 out of 35
PCs to use, i.e., SSPC1 and SSPC12 as illustrated in the scatter
plot of Figure 3.12(b). Moreover, it uses SSPC1 repeatedly to
classify the subjects. The C4.5 decision tree inducer can use a
feature more than once to classify, as long as it maximizes the
information gain.
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(a)
(b)
Figure 3.12: Decision tree diagrams and scatter plots showing the
distribution of subject scores for the PCs chosen by the
classifier. No pre-selection of features. (a): MSA vs HC;
(b): PSP vs HC (Note: For the PSP group only two PCs
[SSPC1 & SSPC12] were used in the classification).
3.3.3 Decision trees with reduced number of features
In Section 3.3.2 we noticed an overlapping distribution of sub-
ject scores of the chosen PCs by the classifier with no clear cut
between the PD and HC. To improve robustness, we considered
to use only the first two components obtained from the PCA
process since they depict the highest variance. Figure 3.13(a)
is an example of one of the 38 classifiers for the PD vs HC
group generated during the LOOCV process, that is the classi-
fier constructed after removing one subject from the training
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set, which is thereafter used for testing the left-out subject. For
the purpose of comparing with the SR method, we reproduce
some of the LOOCV results from the previous study by Mudali




Figure 3.13: The decision tree diagrams and scatter plots showing the
distribution of subject scores for the two first features
obtained from the LOOCV process. (a): PD vs HC; (b):
MSA vs HC; (c): PSP vs HC.
The scatter plot in Figure 3.13(a) shows that there is no clear
cut for the classifier to separate the PD and HC groups. This
is because the subject scores for both PD and HC are overlap-
ping. As seen from the tree diagram, the classifier chooses one
threshold for each of the two given PCs to correctly classify
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Table 3.1: Classifier LOOCV performance for reduced number of fea-
tures, i.e, the first two components according to the highest
amount of variance. The column Perf. indicates the per-
centage of subject cases correctly classified, Sensitivity the
percentage of correctly classified patients, and Specificity
the percentage of correctly classified healthy controls.
Group Perf. Sensitivity Specificity
PD (38) 63.2 100 22.2
MSA (39) 74.3 83.3 76.2
PSP (35) 80 70.6 88.9
all PD subjects (100% sensitivity), but misclassifies 7/18 HC
subjects and the test subject (22.2% specificity). That is to say,
the decision boundaries found by the classifier were not suc-
cessful at efficiently separating the two groups. In this case,
even classifiers which use non-axis aligned decision boundaries
may not perform well. Accordingly, there is a need to rescale
or modify the subject scores (like for the SR method) so that
the classifier can find better decision boundaries to efficiently
separate the groups.
Unlike the PD-HC group, the MSA-HC group as illustrated
in Figure 3.13(b) has a better separation, with the two decision
boundaries chosen by the classifier. Only 6/39 subjects overall
are misclassified. Important to note is that for the PSP-HC
group, the classifier uses only one feature SSPC1 out of the
available two features to separate the two groups and 5/17 PSP
subjects are misclassified.
3.3.4 Decision trees with subject z-score on a combined pattern as
a single feature
In the next experiment, the subject z-score determined by the
SR method in the study by Teune et al. [2013] is used as a
feature for the decision tree classification. This feature is the
result of a linear combination of the best PCs according to
AIC (for details see Section 3.3.1). Important to note is that
we submitted only this single feature (the subject z-score) to
the decision tree classifier to separate the patient group from




(a) PD vs HC (b) MSA vs HC (c) PSP vs HC
Figure 3.14: The trees obtained after using subject z-score on the com-
bined pattern as a feature for classification.
Table 3.2: Summary of the decision tree classification with the z-score
on the combined pattern as a feature.
Group Perf. Sensitivity Specificity
PD (38) 79 80 77.8
MSA (39) 87.2 90.5 83.3
PSP (35) 91.4 82.4 100
In Figure 3.14a the tree chooses a cutoff value 0.36 as the
threshold of the single z-score feature to divide the dataset,
with 14 out of 18 healthy controls and 16 out of 20 PD sub-
jects correctly classified. These results correspond to the 80%
sensitivity and 77.8% specificity at z-score cutoff value of 0.45
as reported in the study by Teune et al. [2013]. That the cutoff
values are not identical can be explained as follows. Since the
z-scores take a discrete number of values, there can be a small
interval of cut-off values which lead to the same sensitivity and
specificity (for both the SR and DT method). The decision tree
method uses a mechanism called information gain to sort the
thresholds in ascending order and then chooses the first thresh-
old. For example, the cut-off interval for the PD group was
[0.36,0.45] (with the same sensitivity and specificity), and the
decision tree method chose the first which is 0.36. For testing
new data samples, a mid-value threshold should be considered
to avoid a reduction in specificity.
Interesting is that the DT method produced exactly the same
values for sensitivity and specificity as the SR method of Teune
et al. [2013], although with small differences in z-score cut-off
values. That is to say, at thresholds 0.65 and 0.88 the DT results
correspond to the 90.5% sensitivity, 83.3% specificity for the
MSA group, and the 82.4% sensitivity, 100% specificity for the
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PSP group, respectively, in the study by Teune et al. [2013].
Therefore, with the same single feature (z-score) obtained from
a linear combination of the best PCs, the decision tree method
is as capable as the SR method (with optimal cut-point value
determined from the ROC curve) to obtain high classification
performance.
Appendix 3.A illustrates in more detail that maximising
the information gain by the DT method and maximising the
Youden index [Youden, 1950; Schisterman et al., 2005] in the
SR method lead to identical results. We conjecture that this
identity holds in more generality, although we do not have a
proof at this point.
3.3.5 Pairwise disease-group comparisons
In pairwise binary classification we do direct comparisons of
each disease against another (that is, excluding the healthy
group).
In this experiment, the LOOCV procedure is carried out as
usual, but we combine the SR procedure and decision tree
method in two different ways. In the first approach, the subject
scores of the best components obtained by the SR procedure
and AIC (that is, without linearly combining them) are used as
features for training the decision tree classifier. In the second
approach, we linearly combine these best components to form
one pattern and the subject score on the combined pattern is
used for training, as in Section 3.3.4. The left-out subject is then
tested on the best components (approach 1), or the combined
pattern (approach 2).
Table 3.3: Pairwise disease-group comparisons: Classifier LOOCV per-
formance for (1) subject scores on PCs selected by the SR
Procedure and AIC; and (2) subject scores on the combined
pattern. For each pair of disease groups A and B, Sensitivity
is the percentage of correctly classified subjects of group A,
and Specificity the percentage of correctly classified subjects
of group B.
Subject scores on individual PCs Subject scores on combined pattern
Group Perf. Sensitivity Specificity Perf. Sensitivity Specificity
PD vs MSA (41) 75.6 70 81 90.2 90 90.5
PD vs PSP (37) 70.3 85 52.9 81.1 80 82.4
MSA vs PSP (38) 63.2 66.7 58.8 65.8 61.9 70.6
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The PD vs MSA group performs better than the other com-
parisons for both individual and combined PCs. Similarly, the
PD vs PSP group performs well, especially when the PCs are
combined. Note that the performance is lowest for the PSP
group versus the MSA group. This can be attributed to the
fact that PSP and MSA have a quite similar disease pattern
[Eckert et al., 2008]. As can be seen, combining of PCs to form
one pattern is always better than using individual PCs for the
disease pairwise comparisons.
3.4 discussion
The SR method was found to work better than the DT method,
especially when considering all or a few features for the DT
method. In most cases the major difference was notable in the
performance of the PD vs HC group, which can be attributed
to the fact that the PD-related pattern is very similar to the
healthy pattern. Additionally, with the PD vs HC comparison,
the principal components generated have less variance. Hence,
a combination of several best components yields better results,
which is exactly what the SR method does.
Furthermore, when the same single z-score feature corre-
sponding to the combined pattern in the SR method is used
in the DT classification (see Section 3.3.4), the performance
is as high as that of the stepwise regression method [Teune
et al., 2013]. The pairwise disease comparisons yielded quite an
impressive performance, especially for the PD vs MSA group,
when compared to those in Mudali et al. [2015]. Combining the
SR procedure with the DT method improved performance in
the separation of some disease groups. Therefore, the robust
feature obtained using the SR procedure could be used in the
DT method to improve classification.
3.5 conclusion
Covariance patterns were extracted from four distinct groups
of FDG-PET data using the SSM/PCA method. The subject
scores served as the feature set and input to the C4.5 decision
tree classification algorithm. Classifiers were constructed from
distinct groups for future prediction of new unlabeled subject
images. Validation of classifiers was performed using the leave-
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one-out method. The decision tree results were compared to
the scatter plots and receiver operating characteristic (ROC)
curves obtained in the stepwise regression method.
In some instances, the DT results are still not competitive
with the SR method. This is because for the decision tree
method to maximise classifier performance, it would require
several horizontal and vertical decision boundaries to separate
the dataset (especially for the PD group) since the subject scores
overlap in the feature space. But this could lead to a high gen-
eralization error. Hence, it is preferable to combine the features
to form one robust feature (subject z-score) which is capable
of separating the groups while minimizing the generalization
error. In fact, when we included the z-score feature (as used by
Teune et al. [2013]) in the DT classification, we obtained identi-
cal results for the C4.5 algorithm and the SR method. Therefore,
we can improve the DT method by using the linearly combined
features obtained by the SR procedure. It would be interesting
to find out the performance of a multi-class classification of
all parkinsonian syndromes, i.e., PD vs MSA vs PSP using SR
feature(s) in the DT classification. Unfortunately, with the SR
method in its current form only two groups can be compared.
Nevertheless, given the small size of the current datasets
the decision tree method is highly promising. In addition it
provides a visual understanding of the classification results
and accommodates multi-class classification, as reported in
Mudali et al. [2015]. In the long run, we need to devise means
of obtaining a more diverse set of features and / or a larger set
of training data for the decision tree to perform even better.
3.a appendix : information gain versus youden in-
dex
In this appendix we consider a data set with healthy and non-
healthy cases and compute the optimal split of this data set
based on a single attribute according to two different criteria:
information gain (as used in decision tree classifiers) and the
Youden index. We will illustrate by an example that these two
different measures give identical results.
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Computing the information gain
Let T be a set of cases, where each case belongs to one of k
classes C1, C2, . . . , Ck. (e.g., k = 2, i.e., healthy and disease.) Let
freq(Cj, T) be the number of cases belonging to class Cj.











When T is split in subsets T1, T2, . . . , Tn by some attribute X








Now consider the complete data set T, with attributes X1, X2, . . ..
The proportion of healthy cases is pH , the proportion of dis-
ease cases is pD. Let info(T) be the information (entropy) of T.
(For a pure set, for example if there are only healthy cases,
info(T) = 0.) Consider an attribute X and a split value V of this
attribute. Split the data set T into two subsets T1 and T2:T1 = all cases from T where X 6 VT2 = all cases from T where X > V (3.3)
The expected information of this partition of T is denoted by
info(V)X (T).
The information gain is: gain(V)X (T) = info(T)− info(V)X (T).
In order to find the optimal split of the data set, one computes
gain(V)(X) for all attributes X and all split values V. Then the
attribute X which maximizes gain(V)X is chosen as the first node
of the tree, with V the corresponding split value.
Youden index
For distinguishing between individuals with and without a dis-
ease, the Youden index is often used [Youden, 1950; Schisterman
et al., 2005] as a measure of overall diagnostic effectiveness.
This index is defined by J = TPR− FPR, with TPR the true
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positive rate (fraction of true positives out of all positives), and
FPR the false positive rate (1-fraction of true negatives out of
all negatives). In other words, J is the maximum vertical dis-
tance between the ROC curve and the diagonal or chance line.
Note that TPR equals sensitivity and FPR equals 1-specificity,
so that J is equal to sensitivity+specificity-1.
Example
Consider now an example data set T with six cases, two healthy
(labeled H) and four diseased (labeled D). Let us consider the
disease cases as positives and the healthy cases as negatives.
We now consider all possible choices for the split point; let us
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Figure 3.15: All possible cases for the split point.
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For all these cases we have computed the Youden index and
the information gain gain(V)X (T) = info(T)− info(V)X (T), where
V refers to the possible cases 0,1,2,. . . ,6 for choosing the split
value. Table 3.4 shows the results.
Table 3.4: The Youden index and information gain computed for all
the seven cases.
Case No 0 1 2 3 4 5 6
Youden index 0 0.5 0.25 0.75 0.5 0.25 0
Information gain 0 0.32 0.05 0.46 0.25 0.11 0
As can be seen in Table 3.4, Case 3 has both the highest
Youden index J and the highest information gain gain(V)X (T).
This illustrates the relationship between the information gain
(the mechanism used in the C4.5 decision tree inducer to de-
termine thresholds) and the Youden index used to determine
the best cut-off point (best combination of sensitivity and speci-
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abstract: We apply Generalized Matrix Learning Vector Quantization (GMLVQ)
and Support Vector Machine (SVM) classifiers to fluorodeoxyglucose positron emission
tomography (FDG-PET) brain data in the hope to achieve better classification accuracies
for parkinsonian syndromes as compared to the decision tree method which was used in
previous studies.
The classifiers are validated using the leave-one-out method. The obtained results
show that GMLVQ performs better than the previously studied decision tree (DT)
method in the binary classification of group comparisons. Additionally, GMLVQ
achieves a superior performance over the DT method regarding multi-class classification.
The performance of the considered SVM classifier is comparable with that of GMLVQ.
However, in the binary classification, GMLVQ performs better in the separation of
Parkinson’s disease subjects from healthy controls. On the other hand, SVM achieves
higher accuracy than the GMLVQ method in the binary classification of the other
parkinsonian syndromes.
Keywords: Learning Vector Quantization, Support Vector Machine, Parkinsonian
syndromes, Classification.
4.1 introduction
Diagnosis of neurodegenerative diseases (NDs), especially at
an early stage, is very important to affect proper treatment [Ap-
pel et al., 2015], but it is still a challenge [Silverman, 2004].
Nevertheless, some studies report considerable success in dif-
ferentiating between some of these diseases [Van Laere et al.,
2006]. In fact, promising classification performances were ob-
tained for the multiple system atrophy (MSA) and progressive
supranuclear palsy (PSP) groups versus the healthy control
group in the study [Mudali et al., 2015] where the decision
tree (DT) method was used. The same study showed that dis-
criminating the Parkinson’s disease (PD) group from healthy
controls (HC) on the basis of PET brain scan imaging data
remains a challenge. Therefore, in this chapter other classifica-
tion methods are applied in the hope to improve classification
of parkinsonian syndromes, in particular PD, MSA, and PSP.
The classification methods used in this study are Generalized
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Matrix Learning Vector Quantization (GMLVQ) and Support
Vector Machine (SVM).
LVQ is a method which uses prototypes assigned to each
class. A new case is classified as belonging to the class of the
closest prototype [Kohonen, 1998]. In the training phase, a set
of appropriately chosen prototypes is computed from a given
set of labeled example data. This training process can be based
on a suitable cost function, as for instance in the so-called Gen-
eralized LVQ (GLVQ) introduced in [Sato and Yamada, 1996].
The conceptional extension to matrix-based relevance learn-
ing was introduced in [Schneider et al., 2009]; simpler feature
weighting schemes had been considered earlier in [Hammer
and Villmann, 2002]. Relevance learning provides insight into
the data in terms of weighting features and combinations of
features in the adaptive distance measure. Moreover, GMLVQ
allows for the implementation of multi-class classification in a
straightforward way.
The Support Vector Machine is a supervised learning method
for classifying data by maximizing the margin between the de-
fined classes, see for instance [Burges, 1998; Cristianini and
Shawe-Taylor, 2000]. The aim of SVM training is to minimize
the classification error while maximizing the gap or margin be-
tween the classes by computing an optimally separating hyper-
plane. The training data points that lie closest to the hyperplane
define the so-called support vectors [Cortes and Vapnik, 1995;
Zhang, 1999]. This method was originally designed for binary
classification but has been extended to multi-class classification,
see for instance [Hsu and Lin, 2002] and references therein.
Moreover, several studies including [Magnin et al., 2009; Haller
et al., 2012] have used SVM to classify neurodegenerative dis-
eases with high accuracy. Other examples of SVM applications
like biological data mining are described in [Cristianini and
Shawe-Taylor, 2000].
4.2 method
The data used in this study is described in [Teune et al., 2010].
The brain data were obtained from 18 healthy controls (HC),
20 Parkinson’s Disease (PD), 17 progressive supranuclear palsy
(PSP) and 21 multiple system atrophy (MSA) cases. We apply
the scaled subprofile model with principal component analysis
(SSM/PCA), based on the methods by Spetsieris et al. [Spet-
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sieris et al., 2009], to the datasets to extract features. The
method was implemented in Matlab R2014a. The SSM/PCA
method [Moeller et al., 1987; Moeller and Strother, 1991; Spet-
sieris and Eidelberg, 2011] starts by double centering the data
matrix and then extracts metabolic brain patterns in the form
of principal component images, also known as group invariant
subprofiles. The original images are projected onto the extracted
patterns to determine their weights, which are called subject
scores. The subject scores then form the features that are input
to the classifiers to classify the subject brain images. Because
of the application of the PCA method, the computed subject
scores are dependent on the whole input dataset, an unusual
circumstance in the standard situation. This makes the number
of features extracted equal to the number of samples in the
dataset.
A leave-one-out cross validation (LOOCV) of the classifiers
is performed to predict their performance on new subject cases.
For each run, a subject (test sample) is left out, then the SS-
M/PCA process is performed on the rest of the subjects (train-
ing set) to obtain their scores on the principal components.
These subject scores are then used to train the GMLVQ and the
SVM classifiers. The test subject is projected onto the invariant
profiles to obtain its scores on the extracted profiles. Then the
test subject scores are used to evaluate the trained classifier.
The sensitivity (true positive rate), specificity (true negative
rate) and classifier accuracy are determined. Note that the test
subject is removed before the SSM/PCA process in order to
deal with dependencies of the extracted features on both the
training and test sets. In addition, the test set receiver operating
characteristic (ROC) curve and Nearest Prototype Classifier
(NPC) confusion matrix are computed for all the left-out sub-
jects. The area under the curve (AUC) of the ROC curve is a
measure of the ability of the features (i.e., subject scores on the
principal components) to separate the groups.
For both the SVM and GMLVQ classifiers, we do binary
and multi-class classification. The binary classification involves
comparing the distinct disease groups (PD, PSP, and MSA)
with the healthy control group. The multi-class classification
concerns the comparison of all the groups, i.e., HC versus PD
versus PSP versus MSA (a total of 76 subjects), as well as only
the disease groups, i.e., PD versus PSP versus MSA (a total of
58 subjects). The goal is to determine the class membership
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(healthy or diseased) of a new subject of unknown diagnosis
and also determine the type of parkinsonian syndrome.
For SVM training and testing, we use the Matlab R2014a
functions “fitcsvm” and “predict”, respectively, with default
parameters and a linear kernel, representing a large margin
linear separation in the original feature space. Also, all features
are centered at their mean in the dataset and scaled to have unit
standard deviation. The “fitcsvm” returns an SVM classifier
which can be used for classification of new data samples. It
also provides class likelihoods which can be thresholded for an
ROC analysis. For the SVM multi-class classification we use the
LIBSVM library [Chang and Lin, 2011] with the one-against-
one method, since the previously mentioned Matlab functions
support only binary classification. The one-against-one method
has a shorter training time than the one-against-all, as reported
in [Hsu and Lin, 2002].
As for GMLVQ, we employ it in its simplest setting with one
prototype wk per class. A global quadratic distance measure of
the form d(wk,x) = (x−wk)TΛ(x−wk) is used to quantify
the dissimilarity of an input vector x and the prototypes. The
measure is parameterized in terms of the positive semi-definite
relevance matrix Λ [Schneider et al., 2009]. Both, prototypes
and relevance matrix are optimized in the training process
which is guided by a suitable cost function [Schneider et al.,
2009]. We employed the gmlvq-toolbox [Biehl, 2015], which per-
forms a batch gradient descent minimization with automated
step size control, see [Biehl, 2015] for details. All the results pre-
sented here were obtained using the default parameter settings
of [Biehl, 2015]. After 100 gradient steps, the training errors
and cost function appeared to have converged in all considered
classification problems.
It has been shown theoretically and observed in practice fre-
quently that the relevance matrix in GMLVQ displays a strong
tendency to become singular [Schneider et al., 2009; Biehl et al.,
2015; Bunte et al., 2012]. Generically the relevance matrix is
clearly dominated by very few or even a single eigenvector,
depending on the complexity of the dataset. This feature of
GMLVQ helps to reduce the risk of over-fitting: The effective
number of degrees of freedom remains linear in the dimension
of the feature vectors, while the number of matrix elements
is quadratic. Moreover, GMLVQ provides a low-dimensional
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representation of the dataset which can be employed for dis-
criminative visualization, for instance.
4.3 results
4.3.1 Generalized Matrix Relevance LVQ (GMLVQ)
As mentioned earlier, in order to validate the classifiers the
training process is repeated with one test subject removed from
the training set before applying the SSM/PCA process. This
section presents the LOOCV results for the distinct disease
groups versus the healthy control group in the binary and
multi-class classification. Important to note is that all the fea-
tures (100%) as extracted from the brain image data using the
SSM/PCA method are provided to the GMLVQ classifier. In the
tables, sensitivity (%) is the percentage of correctly classified
patients, specificity (%) the percentage of correctly classified
healthy controls, and AUC is the area under the ROC curve.
In addition, the corresponding results are visualized in terms
of projections on the leading two eigenvectors of the relevance
matrix. This exploits the fact that GMLVQ displays a tendency
to yield low-rank matrices which correspond to an intrinsically
low-dimensional representation of the feature space [Schneider
et al., 2009; Bunte et al., 2012]. Additionally, we include the
corresponding plots showing diagonal and off-diagonal matrix
elements for one LOOCV iteration as an example illustration.
4.3.1.1 Binary Classification
The objective here is to separate the individual disease groups
from the healthy control group. The GMLVQ results are shown
in Table 4.1.
The results in Table 4.1 are much better than those of the
decision tree as reported in [Mudali et al., 2015]. In fact a
tremendous improvement can be seen in the PD vs HC group,
whose LOOCV performance has increased from 63.2% (decision
trees) to 81.6% (GMLVQ). The use of the relevance matrix to
weight features according to their relevance appears to boost
performance. An illustration is shown in Fig. 4.16 where the
training data points are displayed in a feature space of the
two leading eigenvectors of the relevance matrix. Observe that
the subject scores do not overlap after the GMLVQ classifier
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Table 4.1: GMLVQ Classifier performance in LOOCV for the different
data sets (patients vs healthy controls, number of cases in
brackets). The column Perf.(%) indicates the percentage of
subject cases correctly classified per group. Perf. as well
as Sensitivity and Specificity correspond to the Nearest
Prototype Classifier (NPC).
Feature set(size) Perf. (%) Sensitivity (%) Specificity (%) AUC
PD-HC (38) 81.6 75 88.9 0.84
MSA-HC (39) 92.3 90.5 94.4 0.99
PSP-HC (35) 88.6 82.4 94.4 0.97
training phase, which corresponds to error-free classification
of the training set. Further, the resulting AUC measures (for
the different groups) are relatively high. This means that the
GMLVQ weighted features are very suitable for separating the
groups.
Figure 4.16: Illustrations of the results of a single GMLVQ training pro-
cess in the LOOCV of the PD vs HC two class-problem, 1 =
HC, 2 = disease group. Graphs show diagonal relevances
(upper left), and off-diagonal relevance matrix elements
(lower left). The visualization of the training data in terms
of their projection on the two leading eigenvectors of the
relevance matrix is displayed on the right.
As observed in Fig. 4.16, the PD vs HC comparison shows a
clear separation between the PD group and the healthy group.
Apart from a few outliers, most of the data points cluster
around the specific prototypes, i.e., the two bigger circles that
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each represent a class. Further, the relevance matrix histogram
shows the features and their diagonal weights as used in the
classification process. For example, in the PD vs HC group fea-
ture 1 was weighted the highest, implying that feature 1 carries
relevant information required to separate the two groups. As
a matter of fact, the highly weighted feature should be given
more attention, i.e., critically analyze the principal component
image corresponding to this feature to gain insights from the
clinical perspective.
4.3.1.2 Multi-class classification
Here we show the results for the LOOCV of the GMLVQ clas-
sifier on the multi-class datasets, i.e., the classification of all
the four classes, and the three disease classes, respectively. The
latter is considered separately, because the main task in clinical
practice is to distinguish the three parkinsonian syndromes.
Additionally, for the four-class comparison, we include the HC
group because we want to build a classifier which can also
distinguish a healthy subject from the parkinsonian groups.
The results are shown in Tables 4.2 and 4.3 for four-class com-
parison and three disease groups, respectively. Also included
are the scatter plots showing the distribution of training data
points in the two-dimensional projection of the feature space
in a single run of the training process.
Table 4.2: Four-class problem: The table shows the number of sub-
ject images correctly classified for each class in bold and
the overall performance in percentage as obtained in the
LOOCV.
GMLVQ classification HC PD PSP MSA
HC(18) 14 3 1 0
PD(20) 5 13 1 1
PSP(17) 2 2 11 2
MSA(21) 0 1 4 16
Class accuracy (%) 77.8 65 64.7 76.2
Overall performance (%) 71.1
four-class comparison. From the results in Table 4.2,
we notice that most of the misclassified HC subjects are classi-
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fied as PD and vice versa. As already observed in [Mudali et al.,
2015], the PD and HC subjects have a closely related metabolic
pattern. Likewise, the PSP and MSA groups display a similarity,
in view of the fact that four (majority of the misclassification)
MSA subjects are misclassified as PSP.
Table 4.3: Three-class problem: The table shows the number of subject
images correctly classified for each class in bold with the
overall LOOCV performance in percentage.
GMLVQ classification PD PSP MSA
PD(20)) 19 0 1
PSP(17) 2 12 3
MSA(21) 2 3 16
Class accuracy (%) 95 70.6 76.2
Overall performance (%) 81.03
three-class comparison. The classifier results show that
the PD group is clearly separable from the other two disease
groups. On the other hand, the PSP and MSA groups seem
to overlap more strongly. We observe that the majority of the
misclassification for both the PSP and MSA belong to either
classes, which shows that these two groups are quite similar. In
fact, it is known that PSP and MSA are hard to distinguish be-
cause the patients with either disorders show similar reduction
in striatal and brain stem volumes [Eckert et al., 2004].
visualization of the data points. The scatter plots
show the training data points with respect to their projections
on the two leading eigenvectors of the relevance matrix. It can
be observed in Fig. 4.17(a) that the PSP and healthy groups are
clearly separable from the rest of the groups. But a small overlap
exists between the PD and MSA groups even in the training set.
Meanwhile, the three-class comparison in Fig. 4.17(b) shows a
clear separation among the disease groups. This is encouraging




(a) Four class problem; 1=HC, 2=PD, 3=PSP,
4=MSA
(b) Three class problem; 1=PD, 2=PSP, 3=MSA
Figure 4.17: The visualization of the training data with respect to
their projections on the two leading eigenvectors of the
relevance matrix as observed in a single run of GMLVQ
training.
4.3.2 Support Vector Machine (SVM)
Next we show the results of the leave-one-out cross validation
of the SVM classifier for the different groups, both in a binary
and multi-class comparison. Note that, as before, a subject is
left out before the SSM/PCA process.
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4.3.2.1 Binary Classification
Here, the classifier was used to separate each disease group
from the healthy control group to determine its classification
performance. As seen in Table 4.4, apart from the PD vs HC
Table 4.4: SVM classifier LOOCV performance for the different data
sets (patients vs healthy controls, number of cases in brack-
ets). The column Perf.(%) indicates the percentage of subject
cases correctly classified per group, Sensitivity (%) the per-
centage of correctly classified patients, and Specificity (%)
the percentage of correctly classified healthy controls.
Feature set(size) Perf. (%) Sensitivity (%) Specificity (%) AUC
PD-HC (38) 76.3 75 77.8 0.84
MSA-HC (39) 94.9 90.5 100 0.97
PSP-HC (35) 91.4 88.2 94.4 0.92
comparison, the other groups’ performances improve in com-
parison to GMLVQ (cf. Table 4.1). However, the AUC measures
for MSA and PSP are lower than those of GMLVQ, indicating
that it outperforms the SVM when choosing an appropriate
class bias to modify the nearest prototype classification. In com-
parison to the linear SVM in [Mudali et al., 2015], the results
differ because different features have been used. Furthermore,
here the LOOCV is done correctly by removing the test subject
from the training set before applying the SSM/PCA method,
whereas in [Mudali et al., 2015] the SSM/PCA method was
applied to all subjects to obtain the scores before the LOOCV
was performed.
4.3.2.2 Multi-class Classification
We also applied SVM to the multi-class datasets to determine
its performance on larger datasets.
four-class comparison. This involved the comparison
of all the four groups, i.e., HC, PD, PSP, and MSA. In Table 4.5,
the SVM four-group classification accuracy is slightly above
chance level and lower than that of GMLVQ (see Table 4.2). But
the classifier can separate the MSA group from the rest of the
groups with an accuracy of 81%.
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Table 4.5: Four-class problem: The confusion matrix and the overall
performance of the SVM in the LOOCV scheme.
SVM classification HC PD PSP MSA
HC(18) 12 3 2 0
PD(20) 4 12 1 3
PSP(17) 1 2 9 5
MSA(21) 0 2 2 17
Class accuracy (%) 66.7 60 52.9 81.0
Overall performance (%) 65.8
three disease groups. This involved the comparison of
only the disease groups, i.e., PD, PSP and MSA without the
healthy group. The separation of the disease groups using
Table 4.6: Three-class problem: The table shows the confusion matrix
with the number of subject images correctly classified by
the SVM for each class in bold and the overall LOOCV
performance in percentage.
SVM classification PD PSP MSA
PD(20)) 17 1 2
PSP(17) 2 10 5
MSA(21) 3 2 16
Class accuracy (%) 85 58.8 76.2
Overall performance (%) 74.1
SVM yields a better performance accuracy than the separation
of the four groups (including the healthy group). Also, as in
the GMLVQ classification, the PD group appears to be well
separated from PSP and MSA.
4.4 discussion and conclusion
Both GMLVQ and SVM were studied and tested for the binary
and multi-class problems. In the binary classification, GMLVQ
performs better than SVM in the PD vs HC comparison (per-
formance of 81.6%), but both achieve the same sensitivity of
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75%. However, SVM performs better in the MSA vs HC and
PSP vs HC comparisons. For the two-class problems we also
considered the area under the curve (AUC) of the ROC, as it
does not depend on the choice of a particular working point
(threshold, class bias) in the classifier. In terms of the AUC,
GMLVQ was seen to outperform or equal the performance of
the SVM classifier. Additionally, in the multi-class problems,
GMLVQ achieves a better accuracy than SVM.
The GMLVQ relevance matrix, which makes use of an adap-
tive weighting of features according to their discriminative
power, displayed overall superior classification performance.
In particular, for the PD vs HC comparison which has been
challenging to discriminate using decision trees, GMLVQ was
able to separate PD from HC with an accuracy of 81.6%, better
than SVM by a margin of 5.3%. Although SVM classification
performance for the MSA vs HC and PSP vs HC comparisons
is better than GMLVQ, the AUC measures show that GMLVQ
achieves superior binary classification of the distinct groups.
Overall, GMLVQ also achieves a better accuracy for the multi-
class classification. In addition, when it comes to explaining
the results to the physicians, GMLVQ is more intuitive than
SVM. The analysis of the resulting relevance matrix allows for
the identification of particularly relevant features and combi-
nations of features. LVQ methods parameterize the classifier
in terms of prototypes, i.e. in terms of objects which are de-
fined in the feature space. They can be interpreted as typical
representatives of the classes and facilitate discussions with
the domain experts. The relevance matrix in GMLVQ provides
further insights into the structure of the classification problem
as its elements quantify the importance of single features and
pairs of features. This is in contrast to many other classifica-
tion schemes, e.g. the Support Vector Machine, which do not
offer the same degree of direct interpretability in feature space.
These results should trigger further investigations from the
clinical perspective.
It is interesting to compare our method with that of [Rauber
et al., 2015], in which relevant features are selected to construct
effective classifiers. By contrast, in the GMLVQ approach the
features are not pre-selected or reduced but are weighted ac-
cording to their discriminative power via the relevance matrix.
The contribution of individual features to the classification
process varies in accordance to their weight.
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Clearly, the number of cases in the available data set is fairly
small and our findings could be partly skewed by the small
sample size. For instance, leave-one-out validation schemes
are known to frequently yield unreliable estimates of perfor-
mance. It is also possible that the performance of decision trees
in [Mudali et al., 2015], which was found inferior to GMLVQ
and SVM, might improve significantly for larger data sets (see
comparable work in [Westenberg and Roerdink, 2002]). We in-
tend to extend our work in this direction as more data become
available in the future. Moreover, variants of the considered
classifiers could be considered, e.g., SVM with more powerful
kernels or LVQ systems with several prototypes per class or
local distance matrices [Schneider et al., 2009].
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5D I F F E R E N T I AT I N G E A R LY A N D L AT E S TA G E
PA R K I N S O N ’ S D I S E A S E PAT I E N T S F R O M
H E A LT H Y C O N T R O L S
abstract: Parkinson’s disease (PD) is a neurodegenerative disease which is
difficult to diagnose at early disease stages. Brain imaging techniques like [18F]-
fluorodeoxyglucose positron emission tomography (FDG-PET) may aid to identify
disease-related changes in cerebral glucose metabolism. The scaled subprofile model
with principal component analysis (SSM/PCA) is applied to FDG-PET data to extract
features and corresponding patterns of glucose metabolism which can be used to
distinguish PD subjects from healthy controls. From a previous study, the decision
tree (DT) classifier’s performance to separate the PD group from healthy controls was
below chance level. This could be attributed to the small number of subjects in the
dataset, combined with the early disease progression. In this study, we make use of an
additional PD dataset, consisting of subject brain images obtained at a later disease
stage. The features extracted by the SSM/PCA method are used for distinguishing
PD subjects from healthy controls using three classification methods, that is, decision
trees, Generalized Matrix Learning Vector Quantization (GMLVQ), and Support
Vector Machine (SVM) with linear kernel. The classifiers are validated to determine
their capability of classification given new subject data. We compare the classifiers’
performances on the distinct early-stage and late-stage datasets, as well on the combined
datasets. We also use the early and late-stage datasets interchangeably for training and
testing the classifiers. We find that the DT classification performance on the late-stage
dataset is considerably better than in the previous study, where we used early-stage
data. For early-stage patients, the application of the GMLVQ and SVM classifiers
gives a significant improvement as compared to the DT classifier.
Keywords: Parkinson’s disease, SSM/PCA, decision tree classification.
5.1 introduction
Parkinson’s disease (PD) and other parkinsonian disorders such
as progressive supranuclear palsy (PSP) and multiple system
atrophy (MSA) often show overlap in symptoms at an early
disease stage. An accurate diagnosis can only be achieved after
long-term serial assessment by a movement disorders specialist
[Hughes et al., 2002; Osaki et al., 2004]. This is problematic
because early diagnosis is important for selecting appropri-
ate treatments. We use typical patterns of glucose metabolism
delineated by [18F]-Fluoro-deoxyglucose (FDG) PET with the
purpose of differentiating between parkinsonian syndromes.
Such patterns are extracted by applying the scaled subprofile
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model and principal component analysis (SSM/PCA, [Moeller
et al., 1987]) to FDG PET data of healthy controls and patients
[Eidelberg, 2009]. The expression of previously identified pat-
terns can be computed from the scans of new individuals.
These pattern expression values are useful markers for disease
[Niethammer and Eidelberg, 2012].
The decision tree method [Quinlan, 1993] was used in the
previous study [Mudali et al., 2015] to classify parkinsonian
syndromes. However, it was quite a challenge to separate the
PD subjects from the healthy controls. This could be because
the number of subjects in the dataset was not sufficient enough
to train a robust decision tree classifier.
In this study, in addition to the dataset of early stage PD and
healthy controls used in [Mudali et al., 2015], a larger dataset
consisting of brain images of healthy controls and patients
with PD obtained at a later disease stage is also used. It is
desirable to generate a large dataset consisting of brain data
obtained at all stages of disease progression to extract features
which can be used to train a robust classifier. Therefore, we will
investigate whether features that are more suitable to separate
the PD and healthy groups can be extracted from the advanced
disease stage dataset, showing evident disease patterns in the
data; in other words, to extract patterns which are evidently
associated with PD [Eckert et al., 2007].
In our earlier study [Mudali et al., 2015] the number of
subjects was too small to separate the dataset in a training
and test set to assess classifier accuracy. Therefore to estimate
classification performance the Leave-One-Out Cross Validation
(LOOCV) method was used. However, as is well known, the
LOOCV performance results are only an indication of what
can be achieved when training and test sets are defined by
different input data. Since we now have independent PD data
from different sources we can use one as training and the other
as test set to determine classifier accuracy. For comparison with
earlier results we also compute LOOCV performance for the
case of single datasets.
The scaled subprofile model with principal component anal-
ysis (SSM/PCA) method [Moeller et al., 1987; Moeller and
Strother, 1991] is used to extract the discriminative features
from the brain data. Based on these features, the C4.5 decision
tree classification algorithm [Quinlan, 1993] is used for build-
ing classifiers to separate the PD group from healthy controls.
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Decision trees have the advantage of being easily constructed
and understood, hence they provide an insight into the most
important features for classification [Al Snousy et al., 2011].
In previous brain imaging studies several other classifiers
have been used with promising results. An example is the
Support Vector Machine (SVM) which has been used to detect
various neurological and psychiatric diseases [Magnin et al.,
2009; Haller et al., 2012; Orrù et al., 2012]. Another example is
Generalized Matrix Learning Vector Quantization (GMLVQ),
which has been used in many disciplines including image
analysis and bioinformatics, see Yeo et al. [2015]. A strong point
of the prototype-based GMLVQ classifier is that it is intuitive
and easy to interpret. In addition, it provides insight into the
relevance of individual features for the classification [Schneider
et al., 2009]. For this reason, in addition to the decision tree
method, we applied the SVM and GMLVQ classifiers to the
subject scores extracted from the FDG-PET brain image data,
with the aim to study classification accuracy of the methods
given larger and different datasets.
5.2 method
5.2.1 Subjects
Subject brain images were acquired from two hospitals. First,
data of forty nine patients diagnosed with PD according to the
UK Parkinson’s Disease Society Brain Bank criteria were ob-
tained from the Movement Disorders Unit of the Clinica Univer-
sidad de Navarra (CUN), Spain. Clinical and metabolic data of
these patients was previously published in García-García et al.
[2012]. In addition, 19 age-and gender-matched control subjects
without a history of neurologic, psychiatric illness and no ab-
normalities on MRI were included. From the 49 PD subjects, we
randomly selected 20 PD subjects for training the classifier (PD
subjects of dataset D1_CUN, see table 5.2), and 29 for testing
the classifier (PD subjects of dataset D2_CUN/UMCG see table
5.2). Age, gender, disease duration, Unified Parkinson’s Dis-
ease Rating Scale (UPDRS) motor ratings and Hoehn & Yahr
(H&Y) scores did not differ significantly between PD patients
in the two cohorts. Ethical permission for the procedures was
obtained from the Ethics Committee for Medical Research of
the University of Navarra. Written consent was obtained at
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each institution from all subjects following detailed explana-
tion of the testing procedures. All the 19 healthy controls were
added to the training set to make a total of 39 subjects (dataset
D1_CUN).
Second, 20 PD subjects and 18 healthy controls were obtained
from the University Medical Center Groningen (UMCG), more
details are found in [Teune et al., 2010]. The 18 healthy controls
(from UMCG) were added to the test set of 29 PD (dataset
D2_CUN/UMCG, see table 5.2) from CUN to make 47 subjects.
These 18 HC subjects from UMCG were considered for the
test set because the 19 HC from CUN were too few to divide
into the training and test sets. Also, the 20 PD and the earlier
mentioned 18 healthy controls both from Teune et al. [2010]
(dataset D3_UMCG, see table 5.2) were considered for training
and testing the classifiers. This particular dataset D3_UMCG
was obtained at an early disease stage.
The original datasets from the University Medical Center
Groningen (UMCG) and the Clinica Universidad de Navarra
(CUN) are shown in Table 5.1;
Table 5.1: The original datasets as provided from their respective
sources.
Subjects Source
49 PD and 19 HC CUN
20 PD and 18 HC UMCG [Teune et al., 2010]
The following table 5.2 shows the arrangement of the derived
datasets from the original datasets for experiments, i.e., for
training and testing classifiers.
Table 5.2: The arrangement of the datasets as used for both training
and testing of classifiers.
Dataset Description
D1_CUN 20 PD & 19 HC both groups from CUN
D2_CUN/UMCG 29 PD from CUN & 18 HC from UMCG
D3 _UMCG 20 PD & 18 HC both groups from UMCG
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5.2.2 Image acquisition and preprocessing
The CUN subjects were scanned with [18F]fluorodeoxyglucose
Positron Emission Tomography (FDG-PET) under resting condi-
tions. Patients were studied in the ’on’ pharmacological condi-
tion (under the effect of anti-parkinsonian medication). Central
nervous system depressant drugs were withdrawn, and subjects
fasted overnight before FDG-PET scanning. FDG-PET imag-
ing was performed in 3D mode using a Siemens ECAT EXAT
HR+ scanner (Siemens, Knoxville, TN). Image acquisition was
performed in a resting state with the subject’s eyes closed in
a dimly lighted room with minimal auditory stimulation. Im-
ages were reconstructed by means of a filtered back-projection
method using ECAT software (version 7.2; Siemens). Prepro-
cessing of imaging data was performed by SPM8 software
(Wellcome Department of Imaging Neuroscience, Institute of
Neurology, London, UK) implemented in Matlab 8.0 (Math-
works Inc, Sherborn, MA). All images were spatially normal-
ized onto a PET template in Montreal Neurological Institute
(MNI) brain space and then smoothed by a Gaussian filter of 10
mm FWHM. The UMCG FDG-PET brain data was scanned as
described previously by Teune et al. [2010] and preprocessed
in the same way as the CUN data.
5.2.3 Feature extraction, classification and classifier validation
The same steps as those of Mudali et al. [2015] were followed
to extract features from the brain image data in the form of
subject scores on principal components using the SSM/PCA
method [Moeller et al., 1987; Moeller and Strother, 1991]. These
subject scores were the features provided to the decision tree
inducer, GMLVQ and SVM to train and test the classifiers for
the different cohorts. All the extracted features were considered
for building the classifiers. The classifiers’ performance was
determined using leave-one-out cross validation (LOOCV). In
each LOOCV iteration, a subject was removed from the training
set before the SSM/PCA process to obtain features for training
the classifiers. The left-out-subject was then used for testing the
trained classifier.
In anticipation of better classification performance, we used
the dataset D1_CUN which was obtained at a later disease
stage to train the classifier. Then we tested the classifier using
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the subject scores extracted from both dataset D2_CUN/UMCG
(PD group obtained at a later disease stage) and D3_UMCG
(the PD subjects obtained at an earlier disease stage and healthy
controls), see Table 5.2.
The decision tree classifiers are built using the C4.5 decision
tree algorithm designed by Quinlan [1993]. This algorithm takes
subject scores as inputs and outputs corresponding decision
trees as classifiers [Mudali et al., 2015]. Additionally, we use
the gmlvq-toolbox by Biehl [2015] to train and test GMLVQ
classifiers with default parameters. Further, for the SVM we
use the linear kernel since the dataset is still small. The Matlab
R2014a functions “fitcsvm” and “predict” are used to train and
test the classifiers respectively, see Mudali et al. [2016b].
5.3 classification results
The data was used to train and test three different types of
classifiers i.e., decision trees (DT), GMLVQ and SVM. The
LOOCV results and the performances of training the classifiers
on one cohort and testing on another are included.
5.3.1 Classifier Leave-one-out cross validation (LOOCV) on dataset
D1_CUN
In this section we present the results obtained after the LOOCV
of the DT, GMLVQ and SVM classifiers on dataset D1_CUN
(39 subjects).
Table 5.3: GMLVQ, SVM, and DT LOOCV performance: Perf. = total
accuracy, Sens. = Sensitivity and Spec. = Specificity with
respect to detecting the disease.
Classifiers GMLVQ SVM DT
Sens.% 100 100 90
Spec.% 89.5 94.7 84.2
Perf.% 94.9 97.4 87.2
Although both GMLVQ and SVM outperform DT in the
LOOCV of dataset D1_CUN (the training set), the DT classifier
is competitive since the difference in the performances is rela-
tively small as can be seen in Table 5.3. We observe that with the
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CUN dataset of PD subjects obtained at a later disease stage,
the DT is capable of separating the groups to a satisfactory
extent.
5.3.2 GMLVQ, SVM and DT performance with dataset D1_CUN
as the training set and D2_CUN/UMCG as the test set
Here we used the later disease stage dataset D1_CUN for train-
ing and dataset D2_CUN/UMCG for testing, which contains
advanced PD subjects from CUN and a HC group from UMCG.
Table 5.4: GMLVQ, SVM, and DT performance. D1_CUN as the train-
ing set and D2_CUN/UMCG as the test set: The table
shows the confusion matrix for the classification of dataset
D2_CUN/UMCG with the overall performance (perf.) in
percentage.
GMLVQ SVM DT
HC PD HC PD HC PD
HC (18 subjects) 14 4 14 4 12 6
PD (29 subjects) 3 26 2 27 3 26
Class accuracy (%) 77.8 89.7 77.8 93.1 66.7 89.7
Overall perf. (%) 85.1 87.2 80.9
As can be seen in table 5.4, for DT only 3 out of 29 PD
subjects from dataset D2_CUN/UMCG are misclassified as
healthy controls with an overall performance of 80.9%. With
respect to GMLVQ and SVM, the only difference is in the PD
group, where SVM correctly classifies just one more PD subject
than GMLVQ. However, both GMLVQ and SVM perform better
than DT due to a higher accuracy on the HC group.
5.3.3 Classifier performance with dataset D1_CUN as the training
set and D3_UMCG as the test set
In the setting discussed in this subsection, the training and
test sets are from two different sites, that is, dataset D1_CUN
is used for training and D3_UMCG for testing. The classifier
results are shown in Table 5.5;
The DT performance as seen in Table 5.5 is lower than that of
80.9% in Table 5.4 when testing with dataset D2_CUN/UMCG.
However, it is higher than the PD group performance of 63.2%
73
differentiation of Parkinson’s disease from healthy controls
Table 5.5: GMLVQ, SVM, and DT performance. D1_CUN as the train-
ing set and D3_UMCG as the test set: The table shows the
confusion matrix for the classification of dataset D3_UMCG
with the overall performance in percentage.
GMLVQ SVM DT
HC PD HC PD HC PD
HC (18 subjects) 14 4 14 4 12 6
PD (20 subjects) 6 14 6 14 7 13
Class accuracy (%) 77.8 70 77.8 70 66.7 65
Overall performance (%) 73.7 73.7 65.8
in Mudali et al. [2015]. Again this means that the decision tree
classifier’s ability to separate the two groups has improved.
On the other hand, both GMLVQ and SVM register the same
performance of 73.7% which is better than that of DT.
5.3.4 Classifier performance with dataset D3_UMCG as the train-
ing set and D1_CUN as the test set
The setting in this subsection is the reverse of that in subsection
5.3.3. At first sight, it may seem surprising to use the early-stage
data set for training. Our motivation for this experiment is to
see whether the early-stage data perhaps already do contain
some features that help to differentiate PD subjects from healthy
controls.
Table 5.6: GMLVQ, SVM, and DT performance. Dataset D3_UMCG as
the training set and D1_CUN as the test set: The confusion
matrix and the overall performance in percentage.
GMLVQ SVM DT
HC PD HC PD HC PD
HC (19 subjects) 18 1 18 1 16 3
PD (20 subjects) 2 18 2 18 10 10
Class accuracy (%) 94.7 90 94.7 90 84.2 50
Overall performance (%) 92.3 92.3 66.7
Using D3_UMCG to train the classifiers and testing with
D1_CUN yielded the same performance of 92.3% for both
GMLVQ and SVM which is better than 66.7% for DT. It is
interesting that the performance is better than in the setting of
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section 5.3.3 (training with the CUN dataset and testing with
respect to the UMCG dataset).
5.3.5 LOOCV of the combined datasets D1_CUN and D3_UMCG
Datasets D1_CUN and D3_UMCG were combined to make
a dataset of 77 subjects arranged into two classes, i.e., 37 HC
and 40 PD subjects. The GMLVQ classifier performance on
the combined dataset was validated using the leave-one-out
method, so as to determine the capability of the classifier to
distinguish between the PD and HC subjects. Table 5.7 shows
the confusion matrix for the two-class problem.
Table 5.7: GMLVQ, SVM, and DT LOOCV performance of the com-
bined datasets D1_CUN and D3_UMCG in two classes: The
confusion matrix and the overall performance.
GMLVQ SVM DT
HC PD HC PD HC PD
HC (37 subjects) 35 2 32 5 24 13
PD (40 subjects) 4 36 4 36 10 30
Class accuracy (%) 94.6 90 86.5 90 64.9 75
Overall performance (%) 92.2 88.3 70.1
The GMLVQ classifier can separate the two groups with a
92.2% accuracy as seen in Table 5.7, with sensitivity of 90% and
specificity of 94.6%. SVM is fairly competitive, with a clearly
lower performance of DT.
Having obtained good GMLVQ accuracy in Table 5.7, we next
applied the GMLVQ classifier where we arranged the data from
the D1_CUN and D3_UMCG datasets into four distinct classes,
i.e., 18 HC from UMCG, 20 PD from UMCG, 19 HC from CUN,
and 20 PD from CUN. This was done in anticipation of the
GMLVQ classification accuracy in separating the CUN subjects
from the UMCG subjects. The results for the four-class problem
are shown in Table 5.8.
In Table 5.8, the GMLVQ classifier is able to separate all the
CUN PD subjects from the rest of the subjects. However, 8 out
of 20 UMCG PD subjects are misclassified as UMCG HC (5
subjects) and CUN PD (3 subjects).
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Table 5.8: GMLVQ LOOCV performance on the combined datasets
D1_CUN and D3_UMCG in four classes: The table shows
the number of test subject images correctly classified for each
class (in bold) with the overall performance in percentage.
CUN HC UMCG HC CUN PD UMCG PD
CUN HC (19 subjects) 17 1 1 0
UMCG HC (18 subjects) 1 17 0 0
CUN PD (20 subjects) 0 0 20 0
UMCG PD (20 subjects) 0 5 3 12
Class accuracy (%) 89.5 94.4 100 60
Overall performance (%) 85.7
5.4 discussion and conclusion
This study has focused on the differentiation between Parkin-
son’s disease and healthy control brain patterns. In the previous
study by Mudali et al. [2015], the decision tree (DT) classifier
displayed relatively poor classification performance as assessed
by leave-one-out cross validation (LOOCV). This poor perfor-
mance was attributed to the small number of subjects in the
dataset used and/or the brain data being obtained at an early
disease stage.
The present study shows that one can obtain high LOOCV
performances for patients at a more advanced disease stage
using different classifiers; see Table 5.3 for the D1_CUN data.
Although GMLVQ and SVM reach the highest performance,
the decision tree classifier also performs very well. It reaches a
performance around 87%, which is a significant improvement
with respect to the results in Mudali et al. [2015], which were
obtained for the D3_UMCG data. The difference between these
data sets is not the number of subjects, but the fact that the
D1_CUN data set corresponds to a later disease stage, with
more metabolic changes than the early disease stage dataset.
Hence, the disease pattern is more pronounced and the ex-
tracted features apparently are more informative with respect
to separating the late-stage PD subjects from healthy controls.
The availability of a data set from CUN with a larger num-
ber of subjects, as well as data sets from different sites (i.e.,
CUN and UMCG), allowed us to perform a number of addi-
tional tests. When D1_CUN was used as the training set and
D2_CUN/UMCG as the test set (in both data sets the PD sub-
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jects are from CUN), the performances of GMLVQ and SVM
was still very good (85% and 87%, resp), while with 81% the
DT was still competitive; see Table 5.4.
When D1_CUN was used as the training set and D3_UMCG
as the test set (now the PD subjects are from CUN and UMCG,
respectively), the performances are significantly lower for all
classifiers; see Table 5.5. Comparing the results with Table 5.4
we see that the main reason is the higher percentage of PD
subjects in the test set that are misclassified as healthy controls.
As before, the explanation is that in this experiment the PD
subjects in the test set are early stage patients from UMCG,
which are hard to distinguish from healthy controls.
Somewhat surprisingly, training with the early-stage UMCG
data and testing with respect to the late-stage CUN data yields
much better performance than vice versa for the GMLVQ and
SVM classifiers, as can be observed by comparing Tables 5.5
and 5.6. Training on early stage data with the GMLVQ and
SVM classifiers seems to infer the subtle differences between
early-stage PD and HC subjects, which then can be successfully
used for the distinguishing late-stage PD from HC. Although in
late stage data the differences between PD and HC will be more
pronounced, training on such data is apparently less effective
for classification when the test set contains early-stage patients
which are quite similar to healthy controls. For the DT classifier,
no significant improvement is seen when comparing Tables 5.5
and 5.6. The decision tree needs to take separate decisions
on many features, while GMLVQ and SVM can handle linear
combinations of feature values. For the DT this leads to the
problem of overfitting and limited generalizability, especially
when the number of subjects is relatively small. With pruning
(feature selection) the overfitting problem can be reduced, but
at the cost of lower performance; see [Mudali et al., 2015] for a
more extensive analysis.
The fact that early-stage PD subjects from the UMCG dataset
are closer to healthy controls than to the late-stage PD samples
in the CUN dataset can also clearly be inferred from Table 5.8.
In this 4-class problem, the CUN PD subjects can be perfectly
identified (no misclassification errors). Most errors occur for
UMCG PD subjects that are misclassified as UMCG HC. Also,
three of the PD UMCG subjects are misclassified as CUN PD
subjects, suggesting that these three subjects are closer to late-
stage than early-stage patients. Therefore it could be interesting
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to explore in detail the relationship between these three PD
UMCG subjects and the CUN subjects and, in particular, to
extensively study the corresponding subject brain images.
On the combined datasets D1_CUN and D3_UMCG (2-class
problem, all PD combined, all HC combined), the classifiers
are also able to differentiate between Parkinson’s disease and
healthy controls with good performances as seen in Table 5.7,
especially for the GMLVQ and SVM classifiers.
In conclusion, this study has shown that by applying state-of-
the-art classifiers to FDG-PET brain data, Parkinson’s disease
subjects can be separated from the healthy controls with high
accuracy. We have shown that the application of the GMLVQ
and SVM classifiers can give a significant improvement as
compared to the DT classifier, especially for classifying early-
stage patients.
With respect to understanding the behaviour of the classifica-
tion methods, the GMLVQ and DT methods have proven to be
more intuitive than SVM. Moreover, they can handle computa-
tionally very large feature sets. When both high accuracy and
intuitive understanding of the classifier is desired, the GMLVQ
method can be recommended.
We expect that the classifier performance will show further
improvement, even for early-stage brain data, when the number
of subjects in the training dataset further increases. This is the
ultimate goal of the GLIMPS project [Teune et al., 2012], which
aims at establishing a large database of FDG-PET scans from
the Netherlands and abroad.
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6.1 summary and discussion
N eurodegenerative diseases continue to be a chal-lenge in the developed society where the life expectancyis high. If measures are not put in place, these diseases
will continue to affect the elderly and increase the mortality
rate. Since they progress slowly, they are not easy to diagnose at
an early stage. Moreover, they portray similar disease features,
which makes them hard to differentiate.
In this thesis, our objective was to devise techniques to ex-
tract biomarkers from FDG-PET brain data for the prediction
and classification of neurodegenerative diseases, in particular
parkinsonian syndromes. Therefore we used Principal Compo-
nent Analysis (PCA) in combination with the scaled subprofile
model (SSM) to extract features from the brain data to classify
these disorders. Furthermore we validated the classifiers.
A background to neurodegenerative diseases and brain imag-
ing techniques was given in chapter 1. In chapter 2 we started
our study of classification of parkinsonian syndromes using
decision trees because they are easy to understand. Features in
the form of subject scores were extracted from the FDG-PET
brain data using the SSM/PCA method. These features were
input to the C4.5 decision tree inducer to train classifiers. The
classifiers were validated with a leave-one-out method. The
results showed that the decision tree can separate the MSA
and PSP subjects from healthy controls but is unsuccessful
when it comes to the PD subjects, although DT accuracy im-
proved after reducing the number of features to include only
the most relevant ones in the classification process. Therefore,
we concluded that since the FDG-PET activation pattern of
PD patients (especially at an early disease stage) and healthy
controls is similar, the two groups are hard to separate. Ad-
ditionally, the size of the data sets used in this chapter was
too small to achieve better results. Pairwise comparisons of
disease groups (without the healthy group) yielded a better
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classification performance. Other classifiers like LDA, nearest
neighbors, CART, random forests, etc., were also applied to
the same data but they were not exceptional in terms of the
classification. The decision trees also helped us to visualise
the classification results, hence providing an insight into the
distribution of features.
In chapter 3, we compared the decision tree method to the
stepwise regression (SR) method which aims at linearly combin-
ing a few “good” PCA components. The SR method performed
better than the DT method in the classification of the parkin-
sonian syndromes. This is because the SR method combines
the best features into one robust feature for classifying the
Parkinsonian syndromes, unlike the DT method which uses
the features individually. Interestingly, we found that when the
same robust feature is provided to the DT inducer as input,
the accuracy is equally high. Therefore, combining the two
methods, i.e., combining features using the SR procedure and
providing them to the DT method for classifying the syndromes
is feasible. An advantage of the DT classifier is that it can be
applied to multi-class problems, unlike the stepwise regression
method.
The decision tree method was our initial option for the clas-
sification of neurodegenerative diseases due to the fact that
decision trees are intuitive and easy to understand. However,
having obtained not completely satisfactory results in the pre-
vious chapters, we opted to try other classification methods in
chapter 4. In this chapter, we applied the GMLVQ and SVM
classifiers to Parkinsonian syndrome data in the hope to achieve
better classification results. As before, we used the SSM/PCA
method to obtain the features for classification and supplied
them to the GMLVQ and the SVM classifiers to classify the sub-
ject image data. The results show that both GMLVQ and SVM
are better than the DT method in the classification of early-stage
parkinsonian syndromes. SVM fairly competes with GMLVQ in
the binary classification, but the Area Under the Curve (AUC)
measures show that GMLVQ is superior. With the multi-class
problems, GMLVQ achieved a better classification accuracy
than SVM. Unlike SVM, with GMLVQ the results are easier to
interpret in the form of the diagonal and off-diagonal matrices.
After acquiring a dataset with a larger number of PD scans,
moreover at a later disease stage, we applied the decision tree,
GMLVQ and SVM classification methods to this data. In chap-
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ter 5, we compared the different classifier performances regard-
ing the separation of the ‘late-stage’ PD group from the healthy
controls. The decision tree leave-one-out cross validation per-
formance results for this particular group (advanced stage) are
far better than those in chapter 2. Furthermore, the GMLVQ
and SVM perform much better than the decision tree in the
separation of the PD and HC groups for early disease-stage
patients. On the other hand, GMLVQ and DT are more intu-
itive than SVM. They both can handle very large feature sets.
We found out that training and testing using a bigger dataset
including late-stage PD brain images yields much better results
than the smaller size dataset with early-stage PD scans only.
Therefore, large training datasets aid in better classification
of neurodegenerative diseases. All the classification methods
used in this thesis performed well with the later disease stage
data. We conclude that GMLVQ and decision tree methods can
be recommended for further research on neurodegenerative
disease classification and prediction.
6.2 future work
In chapter 2 the decision tree method was applied to small size
datasets. It is important to generate more data and apply the
decision tree method to larger size datasets in anticipation of
better results. Moreover, data can encompass different imaging
modalities like MRI, fMRI, DTI, etc. Also, it is important to
visualise the decision tree diagrams to look critically at the
thresholds used in the classification. By doing so, the disease
stage can be determined. This can be achieved by displaying
the subject scores (on the features chosen by the classifier) on
scatter plots or histograms to determine the distance of subject
scores from the thresholds. Additionally, it could be interesting
to explore the decision trees using interactive visualisation
techniques.
Since in chapter 3 we see an outstanding performance of the
stepwise regression (SR) procedure in the separation of two
groups, a deeper look into the extension of the SR procedure to
include the comparison of more than two groups is interesting.
In chapter 5, the leave-one-out cross validation of the com-
bined early/late disease stage data yielded better results. There-
fore, we propose that large datasets of subjects at several phases
of disease progression should be accumulated to aid in building
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robust classifiers. These classifiers can then be used to predict
the types and stages of neurodegenerative diseases.
Finally, in addition to subject scores, other types of features
could be generated from FDG-PET or MRI data to improve the
classification of parkinsonian syndromes.
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S A M E N VAT T I N G
voorspelling van neurodegeneratieve aandoenin-
gen op basis van functionele hersenafbeelding
N eurodegeneratieve aandoeningen leiden tot uitda-gende problemen voor maatschappijen met een hogelevensverwachting. Als er niets aan gedaan wordt zul-
len deze aandoeningen effect blijven hebben op ouderen en het
sterftecijfer blijven verhogen. Aangezien ze een traag verloop
hebben zijn ze lastig in een vroeg stadium te herkennen. Bo-
vendien vertonen patiënten met deze aandoeningen allemaal
vergelijkbare ziekteverschijnselen, wat ze lastig te onderschei-
den maakt.
In dit proefschrift was het doel technieken te onderzoeken
om biomarkers te verkrijgen uit hersenbeelden die gemaakt
zijn door middel van Positron Emissie Tomografie (FDG-PET),
om langs die weg neurodegeneratieve aandoeningen te kunnen
voorspellen en classificeren, in het bijzonder Parkinson-achtige
aandoeningen. We hebben principale component-analyse (PCA)
gecombineerd met het geschaalde subprofielmodel (SSM) om
kenmerken uit de hersenbeelden te halen die geschikt zijn
voor classificatie. De resulterende classificatiemethoden zijn
gevalideerd.
Hoofdstuk 1 geeft achtergrondinformatie over neurodegene-
ratieve aandoeningen en technieken voor het in beeld brengen
van het brein. In hoofdstuk 2 beginnen we onze studie naar de
classificatie van Parkinson-achtige aandoeningen met “decision
trees” (besluitbomen), aangezien deze laatste vrij intuïtief zijn.
Kenmerken in de vorm van subject-scores zijn uit de hersen-
beelden gehaald met de SSM/PCA methode. Deze kenmerken
zijn vervolgens doorgegeven aan het C4.5 algoritme om een
besluitboom te trainen. Deze is vervolgens gevalideerd met
de “leave-one-out” methode. De resultaten laten zien dat een
besluitboom onderscheid kan maken tussen gezonde proefper-
sonen en MSA (multiple system atrophy) of PSP (progressive
supranuclear palsy) patiënten, maar meer moeite heeft met
PD (Parkinson’s disease) gevallen, hoewel de resultaten van
de besluitboom verbeteren door alleen de meest relevante ken-
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merken te gebruiken. We concluderen dat PD patiënten lastig
te onderscheiden zijn van de gezonde controlegroep (zeker
als de aandoening nog in een vroeg stadium is), en dat dit
komt omdat de FDG-PET activatiepatronen voor deze twee
groepen vergelijkbaar zijn. Bovendien was de hoeveelheid data
die tot onze beschikking stond in dit hoofdstuk te klein om
betere resultaten te bereiken. Paarsgewijze vergelijkingen van
de ziektegroepen (zonder de controlegroep) leverde betere
classificatieresultaten op. Andere classificatie-algoritmen, zo-
als lineaire discriminant-analyse (LDA), “nearest neighbors”,
classificatie-en-regressiebomen (CART), “random forests”, enz.
zijn ook uitgeprobeerd, maar lieten geen uitzonderlijk goede
resultaten zien. De besluitbomen zijn bovendien van belang
voor het visualiseren van de classificatieresultaten, en geven
hiermee inzicht in de distributie van de kenmerken.
In hoofdstuk 3 vergelijken we besluitbomen met stapsgewijze
regressie (SR), welke probeert enkele “goede” PCA componen-
ten lineair te combineren. De SR methode was effectiever dan
de besluitbomen voor het classificeren van Parkinson-achtige
aandoeningen. Dit komt omdat de SR-methode de beste ken-
merken combineert tot één robuust kenmerk voor het classifice-
ren van de Parkinson-achtige aandoeningen. De besluitbomen
daarentegen gebruiken de individuele kenmerken afzonderlijk.
Interessant genoeg zien we dat de accuratesse even goed is
als hetzelfde robuuste kenmerk werd gebruikt voor het maken
van een besluitboom. Het is dus zeker mogelijk de twee metho-
den te combineren waarbij de kenmerken door de SR-methode
geleverd worden en de classificatiemethode een besluitboom
gebruikt. Het voordeel van het gebruik van een besluitboom is
dat die, in tegenstelling tot de stapsgewijze regressiemethode,
in staat is meer dan twee groepen te onderscheiden.
De besluitboom-methode was onze eerste keuze voor het
classificeren van neurodegeneratieve aandoeningen vanwege
het feit dat besluitbomen makkelijk te begrijpen zijn. Echter,
vanwege de niet erg bevredigende resultaten in de eerdere
hoofdstukken, onderzoeken we in hoofdstuk 4 enkele andere
classificatie-algoritmen. In dit hoofdstuk passen we “Generali-
zed Matrix Learning Vector Quantization” (GMLVQ) en “Sup-
port Vector Machine” (SVM) classificatie-algoritmen toe op data
van Parkinson-achtige aandoeningen in de hoop hiermee betere
classificatieresultaten te behalen. Net als eerder gebruiken we
de SSM/PCA-methode om geschikte kenmerken voor de classi-
ficatie te verkrijgen en geven we deze door aan de GMLVQ- en
98
samenvatting
SVM-methoden. Uit de resultaten blijkt dat zowel GMLVQ en
SVM beter zijn dan besluitbomen in het classificeren van in een
vroeg stadium optredende Parkinson-achtige aandoeningen.
SVM is praktisch even goed als GMLVQ in binaire classificatie,
maar de “Oppervlakte Onder de Curve”-maten laten zien dat
GMLVQ beter is. Als het gaat om het onderscheiden van meer
(dan twee) groepen is GMLVQ beter dan SVM. In tegenstelling
tot SVM zijn de GMLVQ resultaten makkelijk te interpreteren
in termen van diagonale en neven-diagonale matrices.
We passen de besluitboom-, QMLVQ- en SVM-methoden
ook toe op een later verkregen dataset met een groter aan-
tal scans van patiënten in een verder gevorderd stadium van
PD. In hoofdstuk 5 vergelijken we de mate waarin de verschil-
lende methoden de verder gevorderde PD-gevallen van de
gezonde controlegroep kunnen onderscheiden. De “leave-one-
out cross validation” resultaten voor de besluitbomen zijn hier
veel beter dan de resultaten in hoofdstuk 2. De GMLVQ- en
SVM-methoden zijn veel beter in staat dan de besluitbomen
om de vroege PD-gevallen te onderscheiden van de gezonde
controlegroep. Aan de andere kant zijn GMLVQ en besluitbo-
men intuïtiever dan SVM. Ze kunnen beide erg grote datasets
aan. We komen tot de conclusie dat trainen (en testen) met
een grotere dataset waar ook verder gevorderde PD-gevallen
in voorkomen veel betere resultaten geeft dan trainen met
een kleinere dataset waar alleen vroege PD-gevallen in zitten.
Grotere datasets leiden dus tot betere classificatie van neuro-
degeneratieve aandoeningen. Alle classificatiemethoden in dit
proefschrift werken goed met data van patiënten in een verder
gevorderd stadium van de aandoening. We komen zo tot de
eindconclusie dat GMLVQ en besluitbomen interessant zijn
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